细胞株Cell Lines 58-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV58
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID HUES 40
AC CVCL_B173
DR ISCR; 623
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4eda-7803-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 41
AC CVCL_B174
DR ISCR; 624
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4edb-45de-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 42
AC CVCL_B175
DR ISCR; 625
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd5-0467-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=95
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0157.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 43
AC CVCL_B176
DR ISCR; 626
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4edc-aa55-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID HUES 44
AC CVCL_B177
SY HUES44
DR EFO; EFO_0007081
DR ENCODE; ENCBS440AUU
DR GEO; GSM670089
DR ISCR; 2053
WW http://harvard.eagle-i.net/i/00000140-2fd5-6152-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=96
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0158.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 45
AC CVCL_B178
SY HUES45
DR EFO; EFO_0007082
DR ENCODE; ENCBS384VFC
DR GEO; GSM670084
DR GEO; GSM670091
DR ISCR; 1301
WW http://harvard.eagle-i.net/i/00000140-2fd6-0ad9-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=97
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0076.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 46
AC CVCL_B179
DR ISCR; 627
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ede-f186-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 47
AC CVCL_B180
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 48
AC CVCL_B181
SY HUES48
DR EFO; EFO_0007083
DR BioSample; SAMN03732527
DR BioSample; SAMN04096428
DR BioSample; SAMN00849560
DR ENCODE; ENCBS099BXQ
DR ENCODE; ENCBS203SNR
DR ENCODE; ENCBS395IFY
DR ENCODE; ENCBS585ALE
DR GEO; GSM621598
DR GEO; GSM669936
DR GEO; GSM669942
DR GEO; GSM669954
DR GEO; GSM670013
DR GEO; GSM670039
DR GEO; GSM772755
DR GEO; GSM772766
DR GEO; GSM772780
DR GEO; GSM772793
DR GEO; GSM772794
DR GEO; GSM772796
DR GEO; GSM772797
DR GEO; GSM772798
DR GEO; GSM772799
DR GEO; GSM909322
DR GEO; GSM997250
DR ISCR; 774
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd6-53fc-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=87
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0053.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 49
AC CVCL_B182
SY HUES49
DR EFO; EFO_0007084
DR ENCODE; ENCBS684BJP
DR GEO; GSM621603
DR GEO; GSM909323
DR ISCR; 775
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd6-a8fb-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=88
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0054.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 5
AC CVCL_B183
SY HUES-5; HuES5; Hues5; HVRDe005-A
DR hPSCreg; HVRDe005-A
DR ISCR; 106
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2fd7-5a51-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=36
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0018.
CC Registration: Swiss research registry; BAG-hES-IMP-0037.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-008, Steering comm. appl. SCSC04-25(5).
CC Doubling time: 72 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 50
AC CVCL_B184
DR ISCR; 776
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ef6-a6c7-a870-ad6980000000
CC From: Harvard University; Boston; USA.
CC Miscellaneous: Sibling to HUES 51 (CVCL_B185).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 51
AC CVCL_B185
DR ISCR; 777
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ef9-57a7-a870-ad6980000000
CC From: Harvard University; Boston; USA.
CC Miscellaneous: Sibling to HUES 50 (CVCL_B184).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 52
AC CVCL_B186
DR ISCR; 778
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4ef9-d875-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 53
AC CVCL_B187
SY HUES53; HuES53
DR EFO; EFO_0007085
DR ENCODE; ENCBS629MNT
DR GEO; GSM621601
DR GEO; GSM909324
DR ISCR; 779
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd7-c009-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=89
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0055.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 54
AC CVCL_B188
DR ISCR; 780
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4efa-a4f3-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 55
AC CVCL_B189
DR ISCR; 781
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4efa-f833-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 56
AC CVCL_B190
DR ISCR; 782
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4efb-375f-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 57
AC CVCL_B191
DR ISCR; 783
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4efb-c978-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 58
AC CVCL_B192
DR ISCR; 784
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4efc-2af2-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 59
AC CVCL_B193
DR ISCR; 785
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4efc-8607-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID HUES 6
AC CVCL_B194
SY HUES-6; HUES6; HuES6; Hues6; HVRDe006-A
DR BioSamples; SAMEA7771168
DR EFO; EFO_0007086
DR ENCODE; ENCBS153ORV
DR ENCODE; ENCBS271TBU
DR ENCODE; ENCBS530IZG
DR GEO; GSM621700
DR GEO; GSM669885
DR GEO; GSM669886
DR GEO; GSM669887
DR GEO; GSM669888
DR GEO; GSM669889
DR GEO; GSM669890
DR GEO; GSM669891
DR GEO; GSM669892
DR GEO; GSM669893
DR GEO; GSM669894
DR GEO; GSM669895
DR GEO; GSM669897
DR GEO; GSM669898
DR GEO; GSM670080
DR GEO; GSM1112774
DR GEO; GSM1112776
DR GEO; GSM1153528
DR hPSCreg; HVRDe006-A
DR ISCR; 107
RX PubMed=14999088;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2fd8-19b3-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=37
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0019.
CC Registration: Swiss research registry; BAG-hES-IMP-0038.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-009, Steering comm. appl. SCSC04-25(6).
CC Doubling time: 24 hours (PubMed=14999088).
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 60
AC CVCL_B195
DR ISCR; 786
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd8-7904-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 61
AC CVCL_B196
DR ISCR; 787
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4eff-2120-a870-ad6980000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 62
AC CVCL_B197
SY HUES62
DR EFO; EFO_0007087
DR ISCR; 788
DR ENCODE; ENCBS107ECP
DR GEO; GSM621595
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-4f02-28be-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=92
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0065.
CC Miscellaneous: Sibling to HUES 63 (CVCL_B198) and HUES 64 (CVCL_B199).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 63
AC CVCL_B198
SY HUES63
DR EFO; EFO_0007088
DR ENCODE; ENCBS301DIL
DR GEO; GSM621591
DR ISCR; 789
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd8-ce49-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=93
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0066.
CC Miscellaneous: Sibling to HUES 62 (CVCL_B197) and HUES 64 (CVCL_B199).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 64
AC CVCL_B199
SY HUES64; HuES64
DR EFO; EFO_0007089
DR ENCODE; ENCBS015UPH
DR ENCODE; ENCBS078ITI
DR ENCODE; ENCBS183DGX
DR ENCODE; ENCBS389KQW
DR ENCODE; ENCBS479IFR
DR ENCODE; ENCBS614QHK
DR ENCODE; ENCBS666HUG
DR ENCODE; ENCBS766XXZ
DR ENCODE; ENCBS918DAB
DR GEO; GSM621594
DR GEO; GSM669928
DR GEO; GSM669932
DR GEO; GSM669963
DR GEO; GSM669966
DR GEO; GSM669967
DR GEO; GSM669974
DR GEO; GSM772749
DR GEO; GSM772750
DR GEO; GSM772751
DR GEO; GSM772752
DR GEO; GSM772754
DR GEO; GSM772756
DR GEO; GSM772800
DR GEO; GSM772807
DR GEO; GSM772856
DR GEO; GSM772912
DR GEO; GSM772913
DR GEO; GSM772971
DR GEO; GSM772977
DR GEO; GSM772978
DR GEO; GSM772979
DR GEO; GSM772980
DR GEO; GSM773002
DR GEO; GSM773003
DR GEO; GSM997249
DR GEO; GSM1112775
DR GEO; GSM1112834
DR GEO; GSM1112837
DR GEO; GSM1112840
DR GEO; GSM1112841
DR GEO; GSM1227087
DR ISCR; 790
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd9-184c-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=94
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0067.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
CC Miscellaneous: Sibling to HUES 62 (CVCL_B197) and HUES 63 (CVCL_B198).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 65
AC CVCL_B200
SY HUES65
DR EFO; EFO_0007091
DR ENCODE; ENCBS155QMO
DR GEO; GSM621599
DR ISCR; 791
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd9-6a35-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=90
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0056.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 66
AC CVCL_B201
SY HUES66
DR EFO; EFO_0007092
DR ENCODE; ENCBS032OHT
DR GEO; GSM621592
DR GEO; GSM670049
DR ISCR; 792
RX PubMed=19200798;
WW http://harvard.eagle-i.net/i/00000140-2fd9-ae2e-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=91
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0057.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES 67
AC CVCL_B202
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 68
AC CVCL_B203
DR ISCR; 2054
WW http://harvard.eagle-i.net/i/00000140-2fd9-f45f-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=99
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0176.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 69
AC CVCL_B204
DR ISCR; 2055
WW http://harvard.eagle-i.net/i/00000140-2fda-3b9d-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=98
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0178.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 7
AC CVCL_B205
SY HUES-7; HUES7; HuES7; HVRDe007-A
DR hPSCreg; HVRDe007-A
DR ISCR; 108
DR TOKU-E; 4083
RX PubMed=14999088;
RX PubMed=16919167;
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2fda-f5fe-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=38
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0020.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-035, Steering comm. appl. SCSC04-25(7).
CC Doubling time: 48 hours (PubMed=14999088).
ST Source(s): PubMed=16919167
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 70
AC CVCL_B206
DR ISCR; 2056
WW http://harvard.eagle-i.net/i/00000140-2fdb-9b85-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=100
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0177.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 71
AC CVCL_W717
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=695
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0281.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 72
AC CVCL_W718
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=696
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0282.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 73
AC CVCL_W719
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=697
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0283.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 74
AC CVCL_Y572
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=823
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0304.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 75
AC CVCL_W720
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=698
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0280.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES 8
AC CVCL_B207
SY HUES-8; HUES8; HuES8; HVRDe008-A
DR EFO; EFO_0007093
DR ENCODE; ENCBS458EUG
DR ENCODE; ENCBS989VLH
DR GEO; GSM621709
DR hPSCreg; HVRDe008-A
DR ISCR; 109
RX PubMed=17572666;
WW http://harvard.eagle-i.net/i/00000140-2fdb-e5b8-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=39
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0021.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-018, Steering comm. appl. SCSC04-25(8).
CC Doubling time: 48 hours (PubMed=14999088).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HUES 9
AC CVCL_0057
SY HUES-9; HuES9; HUES9; Hues9; HVRDe009-A
DR EFO; EFO_0007094
DR ENCODE; ENCBS579EEW
DR GEO; GSM621718
DR hPSCreg; HVRDe009-A
DR ISCR; 110
RX PubMed=14999088;
RX PubMed=17572666;
RX PubMed=21406692;
WW http://harvard.eagle-i.net/i/00000140-2fdc-4c7e-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=40
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0022.
CC Registration: Swiss research registry; BAG-hES-IMP-0039.
CC Registration: UK Stem Cell Bank (UKSCB); R-05-037, Steering comm. appl. SCSC04-25(9).
CC Doubling time: 24 hours (PubMed=14999088).
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HUES PGD 1
AC CVCL_B208
DR ISCR; 2214
WW http://harvard.eagle-i.net/i/00000140-2fdc-995e-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=101
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0148.
DI NCIt; C85075; Spinal muscular atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 10
AC CVCL_B209
DR ISCR; 2215
WW http://harvard.eagle-i.net/i/00000140-2fdd-64f0-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=103
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0179.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 11
AC CVCL_B210
DR ISCR; 2216
WW http://harvard.eagle-i.net/i/00000140-2fdd-f228-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=104
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0094.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 12
AC CVCL_B211
DR ISCR; 2217
WW http://harvard.eagle-i.net/i/00000140-2fde-e3c4-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=105
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0095.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 13
AC CVCL_B212
DR ISCR; 2218
WW http://harvard.eagle-i.net/i/00000140-2fdf-c558-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=469
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0090.
DI NCIt; C85075; Spinal muscular atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 14
AC CVCL_B213
DR ISCR; 2219
WW http://harvard.eagle-i.net/i/00000140-2fe0-34af-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=489
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0136.
DI NCIt; C85075; Spinal muscular atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 15
AC CVCL_B214
DR ISCR; 2220
WW http://harvard.eagle-i.net/i/00000140-2fe0-b37b-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=498
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0149.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 16
AC CVCL_B215
DR ISCR; 2221
WW http://harvard.eagle-i.net/i/00000140-2fe1-421f-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=499
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0150.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 17
AC CVCL_DF04
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 2
AC CVCL_E084
DR ISCR; 2222
WW http://harvard.eagle-i.net/i/00000140-2fe2-1857-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=580
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0195.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID HUES PGD 3
AC CVCL_B216
DR ISCR; 2223
WW http://harvard.eagle-i.net/i/00000140-2fe1-a80e-a870-ad6980000000
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=102
CC From: Harvard University; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0091.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID huFasM3
AC CVCL_C506
SY M3
DR CLO; CLO_0004296
DR ATCC; HB-11726
RX Patent=US5620889;
CC Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID huFasM38
AC CVCL_2525
SY M38
DR CLO; CLO_0004297
DR ATCC; HB-11465
RX Patent=US5620889;
CC Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID HuG-1
AC CVCL_4845
RX PubMed=2334935;
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HuG1-N
AC CVCL_4846
SY HUG1N
DR CLO; CLO_0050788
DR BioSample; SAMN03472167
DR CCLE; HUG1N_STOMACH
DR Cosmic; 1187276
DR GEO; GSM887145
DR GEO; GSM888217
DR RCB; RCB1179
RX PubMed=22460905;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 33 hours (PubMed=25984343).
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'HuG-N' in Cosmic 1187276.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,10
ST D5S818: 10
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4845 ! HuG-1
SX Male
CA Cancer cell line
//
ID HuG1-PI
AC CVCL_4847
DR CLO; CLO_0050787
DR Cosmic; 1187277
DR RCB; RCB1178
CC Misspelling: 'HuG1-P' in Cosmic 1187277.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,10
ST D5S818: 10
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C5473; Gastric tubular adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4845 ! HuG-1
SX Male
CA Cancer cell line
//
ID HuGC-OOHIRA
AC CVCL_5292
RX PubMed=7541602;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HuGC-OOHIRA
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hughes
AC CVCL_L357
DR BTO; BTO:0005356
RX PubMed=21552385;
RX PubMed=22916246;
CC Doubling time: 17.9 hours (PubMed=22916246).
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID HuH-1
AC CVCL_2956
SY huH-1; HUH-1; huH 1; HuH1; HUh1; HUH1
DR BTO; BTO:0005773
DR EFO; EFO_0006445
DR BioSample; SAMN03473212
DR CCLE; HUH1_LIVER
DR CGH-DB; 452-3
DR Cosmic; 1187328
DR Cosmic; 2023878
DR Cosmic-CLP; 1298146
DR GDSC; 1298146
DR GEO; GSM827219
DR GEO; GSM887146
DR GEO; GSM888218
DR GEO; GSM936761
DR GEO; GSM1374565
DR GEO; GSM1669918
DR JCRB; JCRB0199
RX PubMed=6268479;
RX PubMed=6310497;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 10,12
ST D16S539: 9
ST D18S51: 16
ST D21S11: 33.2
ST D3S1358: 16,17
ST D5S818: 10,13
ST D7S820: 11
ST D8S1179: 10,12
ST FGA: 24
ST Penta D: 12
ST Penta E: 16,18
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HuH-2
AC CVCL_W463
SY huH-2; huH 2
RX PubMed=6310497;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HuH-28
AC CVCL_2955
SY HUH-28; HuH28
DR CLO; CLO_0050855
DR BioSample; SAMN03470952
DR BioSample; SAMN03472037
DR CCLE; HUH28_BILIARY_TRACT
DR ChEMBL-Cells; CHEMBL3308110
DR Cosmic; 924163
DR Cosmic; 1373551
DR GEO; GSM887147
DR GEO; GSM888219
DR JCRB; JCRB0426
DR RCB; RCB1943
DR TKG; TKG 0438
RX CelloPub=CLPUB00275;
RX PubMed=2852388;
RX PubMed=2856443;
RX PubMed=9290701;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 9,12
ST D16S539: 9
ST D18S51: 15
ST D19S433: 13,14.2
ST D21S11: 30,33.2
ST D2S1338: 19
ST D3S1358: 15,16
ST D5S818: 9,12
ST D7S820: 10,11 (JCRB; PubMed=25877200; TKG)
ST D7S820: 10 (RCB)
ST D8S1179: 11
ST FGA: 23
ST Penta D: 9,10
ST Penta E: 13,22
ST TH01: 9
ST TPOX: 8
ST vWA: 17
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HuH-4
AC CVCL_B373
SY huH-4; huH 4; HuH4
DR Cosmic; 934551
RX PubMed=6268479;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Huh-5-2
AC CVCL_X943
SY Huh 5-2; 5-2
DR ChEMBL-Cells; CHEMBL3308089
DR ChEMBL-Targets; CHEMBL613881
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0336 ! Huh-7
SX Male
CA Cancer cell line
//
ID HuH-6
AC CVCL_4381
SY HUH-6; HuH 6; HuH6; HUH6; Huh6
DR BTO; BTO:0001670
DR CLO; CLO_0050851
DR CCLE; HUH6_LIVER
DR Cosmic; 869168
DR Cosmic; 869279
DR Cosmic; 873714
DR Cosmic; 1187329
DR Cosmic; 1237546
DR Cosmic; 1518228
DR Cosmic; 1622750
DR Cosmic; 2162537
DR Cosmic; 2369478
DR GEO; GSM887148
DR GEO; GSM888220
DR GEO; GSM936762
DR RCB; RCB1367
RX PubMed=57894;
RX PubMed=15767549;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 8,11
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HuH-6 Clone 5
AC CVCL_1296
SY HuH-6 clone-5; HUH-6 Clone 5; HUH-6-clone5; HuH-6 cl-5; HuH-6-cl5; HuH-6 cl5; HuH6-Cl5; HUH6 Cl5; HUH6 CL5; Huh6cl5; HuH6-C15; Huh6-c15; HUH6 C15; Huh6c15
DR BioSample; SAMN03471623
DR ChEMBL-Cells; CHEMBL3308701
DR Cosmic; 907070
DR Cosmic-CLP; 907070
DR GDSC; 907070
DR JCRB; JCRB0401
RX PubMed=6301464;
RX PubMed=9290701;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 8,11
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4381 ! HuH-6
SX Male
CA Cancer cell line
//
ID Huh-7
AC CVCL_0336
SY HuH-7; HUH-7; HuH7; Huh7; HUH7; JTC-39; Japanese Tissue Culture-39
DR BTO; BTO:0001950
DR CLO; CLO_0050850
DR CLO; CLO_0050853
DR EFO; EFO_0005384
DR MCCL; MCC:0000232
DR BioSample; SAMN03471912
DR BioSample; SAMN03472130
DR CCLE; HUH7_LIVER
DR CGH-DB; 453-3
DR CGH-DB; 9072-4
DR ChEMBL-Cells; CHEMBL3307515
DR ChEMBL-Targets; CHEMBL614039
DR CLS; 300156/p7178_HuH7
DR Cosmic; 871515
DR Cosmic; 873395
DR Cosmic; 907071
DR Cosmic; 945154
DR Cosmic; 948063
DR Cosmic; 979730
DR Cosmic; 1187330
DR Cosmic; 1351512
DR Cosmic; 1518226
DR Cosmic; 1622751
DR Cosmic; 1995450
DR Cosmic; 2023863
DR Cosmic; 2162528
DR Cosmic; 2321028
DR Cosmic-CLP; 907071
DR ENCODE; ENCBS226AAA
DR GDSC; 907071
DR GEO; GSM207048
DR GEO; GSM481447
DR GEO; GSM565880
DR GEO; GSM816641
DR GEO; GSM827171
DR GEO; GSM887149
DR GEO; GSM888221
DR GEO; GSM936763
DR GEO; GSM1374566
DR GEO; GSM1669919
DR JCRB; JCRB0403
DR KCB; KCB 200970YJ
DR KCLB; 60104
DR Lonza; 244
DR PRIDE; PXD001339
DR RCB; RCB1366
DR RCB; RCB1942
DR TKG; TKG 0206
DR TOKU-E; 3614
DR Wikidata; Q27555640
RX PubMed=9290701;
RX PubMed=12029633;
RX PubMed=15767549;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/Huh7
WW http://huh7.com/
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Huh-7_Crawford_protocol.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-309.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): CLS; Cosmic-CLP; JCRB; KCLB; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11
ST D12S391: 20
ST D13S317: 10 (CLS; RCB)
ST D13S317: 10,11 (Cosmic-CLP; JCRB; KCLB; PubMed=25877200; TKG)
ST D16S539: 10
ST D18S51: 15
ST D19S433: 13,14
ST D1S1656: 16
ST D21S11: 30
ST D2S1338: 19
ST D3S1358: 15
ST D5S818: 12
ST D6S1043: 13,15
ST D7S820: 11
ST D8S1179: 14,15
ST FGA: 22,23
ST Penta D: 12
ST Penta E: 11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18 (CLS)
ST vWA: 16,18 (Cosmic-CLP; JCRB; KCLB; PubMed=25877200; RCB; TKG)
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Huh-7-Lunet
AC CVCL_U459
SY Huh-7 Lunet; Huh-7/Lunet; Huh7-Lunet; Huh7Lunet; Huh7L; Huh-7-Luc-Neo-ET
DR BTO; BTO:0005725
RX PubMed=15596831;
RX PubMed=17079281;
RX PubMed=17552027;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0336 ! Huh-7
SX Male
CA Cancer cell line
//
ID Huh-7-Lunet/Con1
AC CVCL_CW91
SY Huh7 Lunet/Con1; Lunet-Con1
DR BTO; BTO:0005726
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U459 ! Huh-7-Lunet
SX Male
CA Cancer cell line
//
ID Huh-7.5
AC CVCL_7927
SY Huh 7.5; Huh7.5
DR BTO; BTO:0004126
DR EFO; EFO_0005704
DR ENCODE; ENCBS227AAA
DR GEO; GSM816671
RX PubMed=12438626;
RX PubMed=17079281;
RX PubMed=17552027;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Huh-7.5_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0336 ! Huh-7
SX Male
CA Cancer cell line
//
ID Huh-7.5.1
AC CVCL_E049
SY Huh 7.5.1; Huh7.5.1
DR BTO; BTO:0005463
RX PubMed=15939869;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7927 ! Huh-7.5
SX Male
CA Cancer cell line
//
ID Huh-7D12
AC CVCL_2957
SY HuH-7D12
DR ECACC; 01042712
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10
ST D16S539: 10
ST D5S818: 12
ST D7S820: 11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0336 ! Huh-7
SX Male
CA Cancer cell line
//
ID HUH6-eGFP
AC CVCL_M176
RX PubMed=15852273;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4381 ! HuH-6
SX Male
CA Cancer cell line
//
ID HUH7-ins
AC CVCL_HA62
SY Huh7ins
RX Patent=US9365829;
RX PubMed=12621453;
RX PubMed=21084851;
CC Characteristics: Secretes insulin in a regulated manner in response to glucose, calcium and theophylline.
CC Transfected with: HGNC; 6081; INS.
CC Omics: Transcriptome analysis.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0336 ! Huh-7
SX Male
CA Cancer cell line
//
ID Huh7S1
AC CVCL_4W53
RX PubMed=23111106;
CC Selected for resistance to: ChEBI; CHEBI:50924; Sorafenib (Nexavar).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0336 ! Huh-7
SX Male
CA Cancer cell line
//
ID HUIEC
AC CVCL_6C15
SY HUman Intestinal Epithelial Cell
RX PubMed=25821058;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Spontaneously immortalized cell line
//
ID Huker
AC CVCL_9T09
SY Human keratinocytes
DR IZSLER; BS CL 186
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HuKo39
AC CVCL_8283
DR BioSample; SAMN03151717
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HuL-1
AC CVCL_8357
SY HUL-1
DR BioSample; SAMN03151718
DR BioSample; SAMN03472367
DR JCRB; NIHS0231
DR RCB; RCB0077
DR RCB; RCB1457
RX PubMed=15767549;
RX PubMed=20143388;
WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
CC Part of: JFCR45 cancer cell line panel.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: JCRB; NIHS0231; true.
CC Discontinued: RCB; RCB0077; true.
CC Discontinued: RCB; RCB1457; true.
ST Source(s): JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 10
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HuLEC-1
AC CVCL_0A09
SY CDC.EU./HuLEC-1; Human Lung microvascular Endothelial Cell line-1
RX CelloPub=CLPUB00216;
WW http://emoryott.technologypublisher.com/tech/Human_Lung_Microvascular_Endothelial_Cell_Line
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HuLEC-2
AC CVCL_0A10
SY CDC.EU./HuLEC-2; Human Lung microvascular Endothelial Cell line-2
RX CelloPub=CLPUB00216;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HuLEC-5a
AC CVCL_0A11
SY HULEC-5a; HULEC-5A; Human Lung Microvascular Endothelial Cell line-5a
DR ATCC; CRL-3244
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13,14
ST D16S539: 9,10
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Huma 25
AC CVCL_Y906
SY Human mammary 25
RX PubMed=2478401;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y908 ! SVE3
SX Female
CA Transformed cell line
//
ID Huma 62
AC CVCL_Y907
SY Human mammary 62
RX PubMed=2478401;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y905 ! Huma 7
SX Female
CA Transformed cell line
//
ID Huma 7
AC CVCL_Y905
SY Huma-7; Huma7; Human mammary 7
DR BTO; BTO:0004127
RX PubMed=1911442;
RX PubMed=2478401;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y908 ! SVE3
SX Female
CA Transformed cell line
//
ID HUMEMS
AC CVCL_S872
RX PubMed=17547718;
RX PubMed=23882450;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HuMI
AC CVCL_9U06
SY Hu-MI
RX PubMed=1703035;
RX PubMed=8217602;
RX PubMed=9766434;
RX PubMed=11414198;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HuMI-T
AC CVCL_9U07
RX PubMed=8217602;
RX PubMed=9766434;
RX PubMed=11414198;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U06 ! HuMI
SX Female
CA Transformed cell line
//
ID HuMI-TTu1
AC CVCL_9U08
SY TTu1
RX PubMed=8217602;
RX PubMed=11414198;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U07 ! HuMI-T
SX Female
CA Transformed cell line
//
ID HuMI-TTu2
AC CVCL_9U09
SY TTu2
RX PubMed=9766434;
RX PubMed=11414198;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U07 ! HuMI-T
SX Female
CA Transformed cell line
//
ID HUNC-E
AC CVCL_G211
RX PubMed=9600341;
CC Breed/subspecies: Copenhagen.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_Y658 ! R-3327-H
SX Male
CA Cancer cell line
//
ID HUNC-S
AC CVCL_G212
RX PubMed=9600341;
CC Breed/subspecies: Copenhagen.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_Y658 ! R-3327-H
SX Male
CA Cancer cell line
//
ID HuNET
AC CVCL_W948
RX PubMed=11138979;
RX PubMed=22538498;
DI NCIt; C26749; VIP-producing neuroendocrine tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HuNS1
AC CVCL_2526
DR CLO; CLO_0004298
DR EFO; EFO_0002207
DR ATCC; CRL-8644
DR BioSample; SAMN03471205
DR CCLE; HUNS1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 683664
DR GEO; GSM887150
DR GEO; GSM888222
DR IGRhCellID; HuNS1
RX Patent=US4720459;
RX PubMed=22460905;
CC Problematic cell line: Misidentified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H615 ! GM1500-6TG-A11
SX Male
CA Transformed cell line
//
ID HuO-3N1
AC CVCL_1297
SY HuO3N1; HUO3N1
DR BTO; BTO:0002431
DR CLO; CLO_0050099
DR BioSample; SAMN03471625
DR ChEMBL-Cells; CHEMBL3308818
DR ChEMBL-Targets; CHEMBL1075475
DR Cosmic; 909977
DR Cosmic-CLP; 909977
DR GDSC; 909977
DR GEO; GSM320824
DR GEO; GSM1669920
DR JCRB; JCRB0413
DR RCB; RCB2104
DR TKG; TKG 0452
RX PubMed=3862491;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,10
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HuO9
AC CVCL_1298
SY Huo9; HUO9; Hu09
DR BioSample; SAMN03471626
DR ChEMBL-Cells; CHEMBL3308748
DR ChEMBL-Targets; CHEMBL1075476
DR Cosmic; 907072
DR Cosmic; 931040
DR Cosmic-CLP; 907072
DR GDSC; 907072
DR GEO; GSM320823
DR GEO; GSM1669921
DR GEO; GSM1676303
DR GEO; GSM1701638
DR JCRB; JCRB0427
RX PubMed=2691514;
RX PubMed=27397505;
RX PubMed=26351324;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 13
ST D7S820: 10
ST TH01: 9
ST TPOX: 9
ST vWA: 14
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HuO9-M112
AC CVCL_R725
RX PubMed=12405284;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1298 ! HuO9
SX Female
CA Cancer cell line
//
ID HuO9-M132
AC CVCL_R726
RX PubMed=12405284;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1298 ! HuO9
SX Female
CA Cancer cell line
//
ID HuO9N2
AC CVCL_2958
SY HUO9N2; HuO 9N2; O9N2
DR CLO; CLO_0050809
DR BioSample; SAMN03470948
DR GEO; GSM320821
DR JCRB; JCRB0428
DR RCB; RCB2532
DR TKG; TKG 0451
RX PubMed=2691514;
ST Source(s): JCRB; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11
ST D18S51: 13
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 10
ST D8S1179: 15
ST FGA: 24
ST Penta D: 11,13
ST Penta E: 17,21
ST TH01: 9
ST TPOX: 9
ST vWA: 14
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1298 ! HuO9
SX Female
CA Cancer cell line
//
ID HUOA
AC CVCL_X935
DR CGH-DB; 341-2
DR CGH-DB; 9349-4
DR Cosmic; 1152564
DR Cosmic; 877484
RX PubMed=3598277;
RX PubMed=11330945;
RX PubMed=12417041;
RX PubMed=17671176;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HUOCA-II
AC CVCL_A620
SY HVOCA-II
DR Cosmic; 877482
DR Cosmic; 1152562
RX PubMed=2435943;
RX PubMed=10457904;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HuP-T3
AC CVCL_1299
SY HUP-T3; HuPT3; HupT3; HUPT3
DR CLO; CLO_0004299
DR CLO; CLO_0004300
DR EFO; EFO_0006596
DR CLDB; cl1769
DR CLDB; cl1770
DR CLDB; cl1771
DR BioSample; SAMN03472116
DR CCLE; HUPT3_PANCREAS
DR ChEMBL-Cells; CHEMBL3308399
DR ChEMBL-Targets; CHEMBL1075477
DR Cosmic; 907285
DR Cosmic; 1995451
DR Cosmic; 2434096
DR Cosmic-CLP; 907285
DR DSMZ; ACC-259
DR ECACC; 93121055
DR GDSC; 907285
DR GEO; GSM206515
DR GEO; GSM827205
DR GEO; GSM887151
DR GEO; GSM888223
DR GEO; GSM1374567
DR GEO; GSM1669922
DR ICLC; HTL96006
RX PubMed=8454916;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 10,13
ST D18S51: 16,17
ST D21S11: 28,30
ST D3S1358: 15,16
ST D5S818: 10,14
ST D7S820: 12
ST D8S1179: 15
ST FGA: 21,22
ST Penta D: 9,10
ST Penta E: 16,17
ST TH01: 9
ST TPOX: 8,12
ST vWA: 18
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HuP-T4
AC CVCL_1300
SY HUP-T4; HuPT4; HUPT4
DR CLO; CLO_0004301
DR CLO; CLO_0004302
DR EFO; EFO_0002208
DR CLDB; cl1772
DR CLDB; cl1773
DR CLDB; cl1774
DR BioSample; SAMN03472974
DR BioSample; SAMN03473381
DR CCLE; HUPT4_PANCREAS
DR ChEMBL-Cells; CHEMBL3308815
DR ChEMBL-Targets; CHEMBL1075478
DR Cosmic; 907286
DR Cosmic; 2434089
DR Cosmic-CLP; 907286
DR DSMZ; ACC-223
DR ECACC; 93121056
DR GDSC; 907286
DR GEO; GSM827185
DR GEO; GSM887152
DR GEO; GSM888224
DR GEO; GSM1374568
DR GEO; GSM1669923
DR ICLC; HTL95006
DR IGRhCellID; HuPT4
RX PubMed=8454916;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Doubling time: ~38 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,9 (Cosmic-CLP; ECACC; PubMed=25877200)
ST D13S317: 8 (DSMZ)
ST D16S539: 10,11
ST D18S51: 18
ST D21S11: 29,32.2
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 8,11
ST D8S1179: 11,16
ST FGA: 23,24,25
ST Penta D: 9
ST Penta E: 18,19
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HURP-159
AC CVCL_Y094
DR BCRC; 60525
CC Monoclonal antibody target: UniProtKB; Q15398; Human DLGAP5.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HURP-196
AC CVCL_Y095
DR BCRC; 60526
CC Monoclonal antibody target: UniProtKB; Q15398; Human DLGAP5.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HUS-2
AC CVCL_S874
SY HUS2
RX CelloPub=CLPUB00156;
RX PubMed=76683;
RX PubMed=4425030;
RX PubMed=23882450;
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HuSI-L23
AC CVCL_4W54
DR JCRB; JCRB1623
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 14
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Transformed cell line
//
ID HuSI-L23-14-5
AC CVCL_EG62
DR JCRB; JCRB1625
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4W54 ! HuSI-L23
SX Male
CA Transformed cell line
//
ID HuSI-L23-9-10
AC CVCL_4W55
DR JCRB; JCRB1624
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4W54 ! HuSI-L23
SX Male
CA Transformed cell line
//
ID Hut
AC CVCL_M861
DR BioSample; SAMN03151719
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HuT 102
AC CVCL_3526
SY HUT 102; Hut 102; HuT-102; Hut-102; HUT-102; HuT102; Hut102; HUT102; NCI-H102
DR CLO; CLO_0004303
DR CLDB; cl1776
DR ATCC; TIB-162
DR BioSample; SAMN03471941
DR CCLE; HUT102_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0002000000031
DR CCRID; 3142C0001000000051
DR Cosmic; 850197
DR Cosmic; 933552
DR Cosmic; 2361371
DR GEO; GSM887153
DR GEO; GSM888225
DR KCLB; 90102
DR Lonza; 99
DR TKG; TKG 0382
RX PubMed=8547074;
RX PubMed=8806089;
RX PubMed=8806090;
RX PubMed=8806092;
RX PubMed=9738977;
RX PubMed=22460905;
RX PubMed=25355872;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
CC Discontinued: KCLB; 90102; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,11
ST D13S317: 11,13
ST D16S539: 12
ST D5S818: 8,13
ST D7S820: 8,10
ST TH01: 7,8
ST TPOX: 6
ST vWA: 16,19
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HuT 102B
AC CVCL_8329
SY HUT 102B; HUT 102b; HUT-102B; HUT102B
RX PubMed=11021758;
RX PubMed=11737246;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3526 ! HuT 102
SX Male
CA Cancer cell line
//
ID HuT 78
AC CVCL_0337
SY HUT 78; HuT-78; HUT-78; HuT78; Hut78; HUT78; NCI-H78
DR BTO; BTO:0001945
DR CLO; CLO_0004304
DR CLO; CLO_0051010
DR EFO; EFO_0002209
DR MCCL; MCC:0000233
DR CLDB; cl1778
DR CLDB; cl1779
DR ATCC; TIB-161
DR ATCC; CRM-TIB-161
DR BCRC; 60522
DR BCRJ; 0370
DR BioSample; SAMN01821566
DR BioSample; SAMN03471940
DR BioSample; SAMN03473203
DR CCLE; HUT78_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0001CCC000190
DR CCRID; 3131C0001000700027
DR CCRID; 3131C0001001200004
DR CGH-DB; 9026-4
DR ChEMBL-Cells; CHEMBL3307500
DR ChEMBL-Targets; CHEMBL613978
DR CLS; 300338/p653_HUT-78
DR Cosmic; 724829
DR Cosmic; 1551450
DR Cosmic; 2153070
DR Cosmic; 2402468
DR ECACC; 88041901
DR GEO; GSM887154
DR GEO; GSM888226
DR GEO; GSM1374569
DR IGRhCellID; HuT78
DR KCLB; 90078
DR Lonza; 813
DR NCBI_Iran; C185
DR NIH-ARP; 89-218
DR RCB; RCB1934
DR TKG; TKG 0375
DR TOKU-E; 1977
RX PubMed=3495441;
RX PubMed=8806089;
RX PubMed=8806090;
RX PubMed=8806092;
RX PubMed=9738977;
RX PubMed=10570904;
RX PubMed=22460905;
RX PubMed=25355872;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-70.html
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0002&theme=default
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 26 hours (NIH-ARP).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; CLS; PubMed=11416159; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11,12
ST D18S51: 18
ST D21S11: 30
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,11 (ATCC; CLS; RCB; TKG)
ST D7S820: 8 (PubMed=25877200)
ST D8S1179: 12,14
ST FGA: 21,25
ST Penta D: 9
ST Penta E: 13,15
ST TH01: 8,9
ST TPOX: 8,9
ST vWA: 14,15
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HUT 78/HIV-1SF2
AC CVCL_X617
SY HUT 78/HIV-1SF2 (ARV-2); HuT78/HIV-1SF2; HUT78/HIV1SF2
DR NIH-ARP; 279-74
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0337 ! HuT 78
SX Male
CA Cancer cell line
//
ID HUT 78/HIV-2D194
AC CVCL_X682
DR NIH-ARP; 1119-175
RX PubMed=2467304;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0337 ! HuT 78
SX Male
CA Cancer cell line
//
ID HUT 78/HIV-2D205
AC CVCL_X683
RX PubMed=2467304;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0337 ! HuT 78
SX Male
CA Cancer cell line
//
ID HUT 78/SIV-BK28
AC CVCL_X611
DR NIH-ARP; 173-154
CC Doubling time: 3 days (NIH-ARP).
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0337 ! HuT 78
SX Male
CA Cancer cell line
//
ID HUT 78/SIV-BK44
AC CVCL_X616
SY HUT 78/SIV BK44
DR NIH-ARP; 312-155
CC Doubling time: 3 days (NIH-ARP).
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0337 ! HuT 78
SX Male
CA Cancer cell line
//
ID HUT 78/SIVmac251
AC CVCL_X609
SY HUT-78-SIVmac251
DR NIH-ARP; 160-163
RX PubMed=3159089;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0337 ! HuT 78
SX Male
CA Cancer cell line
//
ID HuT-11
AC CVCL_G137
RX PubMed=418410;
RX PubMed=2902939;
CC Problematic cell line: Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939).
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0832 ! Hs 633.T
CA Cancer cell line
//
ID HuT-12
AC CVCL_G138
RX PubMed=418410;
RX PubMed=2902939;
CC Problematic cell line: Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939).
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0832 ! Hs 633.T
CA Cancer cell line
//
ID HuT-13
AC CVCL_G139
RX PubMed=418410;
RX PubMed=2902939;
CC Problematic cell line: Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939).
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0832 ! Hs 633.T
CA Cancer cell line
//
ID HuT-14
AC CVCL_G140
SY HUT 14
RX PubMed=418410;
RX PubMed=2902939;
CC Problematic cell line: Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939).
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0832 ! Hs 633.T
CA Cancer cell line
//
ID HuT11
AC CVCL_G136
RX PubMed=209894;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HUT15
AC CVCL_Y030
SY HUT-15
DR CGH-DB; 187-1
DR CGH-DB; 9176-4
RX PubMed=14581340;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=23381221;
RX PubMed=25120651;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HUT29
AC CVCL_Y031
SY HUT-29
DR CGH-DB; 204-1
DR CGH-DB; 9170-4
RX PubMed=14581340;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=23381221;
RX PubMed=25120651;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID Hut292DM
AC CVCL_B409
SY HUT292DM; Hut292-Dm
DR Cosmic; 929965
DR Cosmic; 932918
RX PubMed=1458487;
RX PubMed=1855224;
CC Caution: It is unclear if Hut292DM is derived from NCI-H292 or is identical to that cell line.
DI NCIt; C45544; Lung mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0455 ! NCI-H292
SX Female
CA Cancer cell line
//
ID HUT70
AC CVCL_Y129
RX PubMed=23381221;
RX PubMed=25120651;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HuT78B1
AC CVCL_0325
SY HUT78B1; HUT78-B1
DR MCCL; MCC:0000218
RX PubMed=8598453;
RX PubMed=15161037;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0337 ! HuT 78
SX Male
CA Cancer cell line
//
ID Hutt45
AC CVCL_HA55
SY H3; H3.iPSC; Hutt45_iPSC
DR GEO; GSM1495405
DR GEO; GSM1502707
RX PubMed=26102527;
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID Hutt60
AC CVCL_HA56
SY H4; H4.iPSC; Hutt60_iPSC
DR GEO; GSM1495406
DR GEO; GSM1502708
RX PubMed=26102527;
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HuTu 80
AC CVCL_1301
SY HUTU 80; Hutu 80; HuTu-80; HUTU-80; Hutu-80; HUTU80; HuTu80; Hutu80
DR BTO; BTO:0005967
DR CLO; CLO_0004305
DR CLDB; cl1780
DR CLDB; cl5208
DR ATCC; CRL-7928
DR ATCC; HTB-40
DR BioSample; SAMN03471124
DR CCLE; HUTU80_SMALL_INTESTINE
DR CCRID; 3111C0001CCC000141
DR ChEMBL-Cells; CHEMBL3307410
DR ChEMBL-Targets; CHEMBL614582
DR CLS; 300218/p481_HuTu-80
DR Cosmic; 687549
DR Cosmic; 907073
DR Cosmic; 1071891
DR Cosmic; 1176592
DR Cosmic; 1223144
DR Cosmic; 2301549
DR Cosmic-CLP; 907073
DR GDSC; 907073
DR GEO; GSM887155
DR GEO; GSM888227
DR GEO; GSM1448180
DR GEO; GSM1669924
DR IZSLER; BS TCL 95
DR KCB; KCB 200721YJ
DR KCLB; 30040
DR LINCS; 50016
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6500159;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://www.addexbio.com/productdetail?pid=49
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-467.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: 26 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-7928; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 10,11
ST D18S51: 14,17
ST D21S11: 31,32.2
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 15
ST FGA: 21,23
ST Penta D: 2.2
ST Penta E: 12,18
ST TH01: 7
ST TPOX: 9,11
ST vWA: 16,18
DI NCIt; C7889; Duodenal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HUUCLEC
AC CVCL_J314
RX PubMed=12227504;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HUVE-12
AC CVCL_3722
SY Human Umbilical Vein Endothelial-12; WC00103
DR BTO; BTO:0004444
DR CLO; CLO_0004306
DR ATCC; CRL-2480
DR BioSample; SAMN03471591
DR Coriell; WC00103
RX PubMed=3654763;
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2480; true.
CC Discontinued: Coriell; WC00103; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HUVE-31
AC CVCL_0E10
SY Human Umbilical Vein Endothelial-31
RX PubMed=3654763;
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HUVE-34
AC CVCL_0E11
SY Human Umbilical Vein Endothelial-34
RX PubMed=3654763;
CC Part of: Wistar Institute Special Collection vascular cell lines.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HUVEC-C
AC CVCL_2959
SY HUV-EC-C
DR BTO; BTO:0001949
DR CLO; CLO_0004307
DR ATCC; CRL-1730
DR BioSample; SAMN01821567
DR BioSample; SAMN01821732
DR BioSample; SAMN03471415
DR CCRID; 3111C0002000000024
DR CCRID; 3131C0001000200023
DR CCRID; 3142C0001000000138
DR IFO; IFO50271
DR IZSLER; BS CL 145
DR Lonza; 1085
DR NCBI_Iran; C554
CC Characteristics: Life expectancy of 50 to 60 population doublings.
ST Source(s): ATCC; JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HUVEC-CS
AC CVCL_0F27
DR ATCC; CRL-2873
RX PubMed=15350190;
CC Discontinued: ATCC; CRL-2873; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2959 ! HUVEC-C
SX Female
CA Finite cell line
//
ID HUVEC/TERT2
AC CVCL_9Q53
SY HUVEC/TERT 2
DR ATCC; CRL-4053
WW http://www.evercyte.com/huvec-tert2-98.html
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D5S818: 15,16
ST D7S820: 9,11
ST D13S317: 11,12
ST D16S539: 9,13
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID HUVS-112D
AC CVCL_3723
SY Human Umbilical Vein Smooth muscle-112D; WC00104
DR CLO; CLO_0004308
DR ATCC; CRL-2481
DR BioSample; SAMN03471592
DR Coriell; WC00104
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2481; true.
CC Discontinued: Coriell; WC00104; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 8,12
ST D16S539: 8,11
ST D5S818: 13
ST D7S820: 10
ST TH01: 7,8
ST TPOX: 6,10
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HuWa1
AC CVCL_4U66
RX PubMed=26363275;
CC Group: Cetacean cell line.
CC Doubling time: ~41 hours (PubMed=26363275).
OX NCBI_TaxID=9773; ! Megaptera novaeangliae
SX Male
CA Finite cell line
//
ID HuWa2
AC CVCL_4U67
RX PubMed=26363275;
CC Group: Cetacean cell line.
OX NCBI_TaxID=9773; ! Megaptera novaeangliae
SX Male
CA Finite cell line
//
ID HuZP3-CHOLec3.2.8.1
AC CVCL_K172
DR ATCC; CRL-2866
RX PubMed=15379548;
CC Transfected with: HGNC; 13189; ZP3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_K173 ! Lec3.2.8.1
SX Female
CA Spontaneously immortalized cell line
//
ID hVEGF-luc/PC3M
AC CVCL_5J43
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119273.
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID HVR-1
AC CVCL_V166
SY HVR1
DR ISCR; 2224
RX PubMed=27346196;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud_Deposito_HVR-1.pdf
CC From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HVR-2
AC CVCL_V167
SY HVR2
DR ISCR; 2225
RX PubMed=27346196;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Linea_HVR-2.pdf
CC From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HVR-3
AC CVCL_V168
SY HVR3
DR ISCR; 2226
RX PubMed=27346196;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud_Deposito_HVR-3.pdf
CC From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HVS-SILVA 40
AC CVCL_3824
SY HVS.SILVA 40
DR CLO; CLO_0004309
DR CLDB; cl1785
DR ATCC; CRL-1773
DR ECACC; 90020105
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC Discontinued: ATCC; CRL-1773; true.
CC Discontinued: ECACC; 90020105; probable.
OX NCBI_TaxID=9483; ! Callithrix jacchus
SX Male
CA Transformed cell line
//
ID HW
AC CVCL_F560
SY TER307
DR IMGT/HLA; 10782
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HWUA-1
AC CVCL_X945
RX PubMed=7194144;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X946 ! HWUA-2
OI CVCL_X947 ! HWUS-1
OI CVCL_X948 ! HWUS-2
SX Female
CA Cancer cell line
//
ID HWUA-2
AC CVCL_X946
RX PubMed=7194144;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X945 ! HWUA-1
OI CVCL_X947 ! HWUS-1
OI CVCL_X948 ! HWUS-2
SX Female
CA Cancer cell line
//
ID HWUS-1
AC CVCL_X947
RX PubMed=7194144;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X945 ! HWUA-1
OI CVCL_X946 ! HWUA-2
OI CVCL_X948 ! HWUS-2
SX Female
CA Cancer cell line
//
ID HWUS-1a
AC CVCL_X949
RX PubMed=7194144;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X947 ! HWUS-1
SX Female
CA Cancer cell line
//
ID HWUS-2
AC CVCL_X948
RX PubMed=7194144;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X945 ! HWUA-1
OI CVCL_X946 ! HWUA-2
OI CVCL_X947 ! HWUS-1
SX Female
CA Cancer cell line
//
ID HX
AC CVCL_3318
SY HT1080 xeno
DR CLO; CLO_0004310
DR ATCC; CRL-12011
RX Patent=US5591624;
CC Group: Retrovirus packaging cell line.
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HX/62
AC CVCL_4995
SY HX-62; HX 62; HX62; Hx62
DR ChEMBL-Cells; CHEMBL3308618
DR ChEMBL-Targets; CHEMBL614686
DR Cosmic; 1609539
DR GEO; GSM313712
RX PubMed=1423261;
RX PubMed=1892748;
RX PubMed=2653399;
RX PubMed=15677628;
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HX1
AC CVCL_Y020
RX PubMed=19833967;
RX PubMed=23828270;
CC Group: Fish cell line.
CC Group: Haploid karyotype cell line.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Female
CA Embryonic stem cell
//
ID Hx104
AC CVCL_Y040
DR Cosmic; 687487
RX PubMed=12068308;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx109
AC CVCL_Y041
DR Cosmic; 688096
RX PubMed=12068308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx110a
AC CVCL_Y042
DR Cosmic; 688039
RX PubMed=12068308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx110b
AC CVCL_Y043
DR Cosmic; 688040
RX PubMed=12068308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx113
AC CVCL_Y044
DR Cosmic; 687488
RX PubMed=12068308;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx117
AC CVCL_Y045
DR Cosmic; 688045
RX PubMed=12068308;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HX118
AC CVCL_H762
SY HX-118; Hx118
DR Cosmic; 688046
RX PubMed=12068308;
WW http://faculty.washington.edu/trawets/archive/Human/skin/hx118/index.html
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx122
AC CVCL_Y046
DR Cosmic; 688097
RX PubMed=12068308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx124
AC CVCL_Y047
DR Cosmic; 687986
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx126
AC CVCL_Y048
DR Cosmic; 688047
RX PubMed=12068308;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx128
AC CVCL_Y049
DR Cosmic; 688042
RX PubMed=12068308;
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hx129
AC CVCL_Y050
DR Cosmic; 724823
RX PubMed=12068308;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx132
AC CVCL_Y051
DR Cosmic; 724880
RX PubMed=12068308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HX138
AC CVCL_H760
SY HX-138
RX PubMed=2245172;
RX PubMed=4001442;
WW http://faculty.washington.edu/trawets/archive/Human/neuroblastoma/hx138/index.html
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx138A
AC CVCL_Y052
DR Cosmic; 688066
RX PubMed=12068308;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H760 ! HX138
CA Cancer cell line
//
ID HX142
AC CVCL_H761
SY HX-142
RX PubMed=2245172;
RX PubMed=4001442;
WW http://faculty.washington.edu/trawets/archive/Human/neuroblastoma/hx138/index.html
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx147
AC CVCL_Y053
SY Hx-147
DR Cosmic; 724861
DR GEO; GSM1374570
RX PubMed=12068308;
CC Omics: Transcriptome analysis.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HX151c
AC CVCL_L441
SY HX151; HX/151; HX/151c
RX PubMed=2441858;
RX PubMed=2475347;
RX PubMed=7751322;
RX PubMed=8347478;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HX155c
AC CVCL_L442
SY HX155; Hx155; HX/155; HX/155c
DR Cosmic; 687511
RX PubMed=2441858;
RX PubMed=2475347;
RX PubMed=8347478;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HX155cisR
AC CVCL_M691
SY HX/155cisR
RX PubMed=8347478;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L442 ! HX155c
SX Female
CA Cancer cell line
//
ID HX156c
AC CVCL_L443
SY HX156; HX/156; HX/156c
RX PubMed=2441858;
RX PubMed=2475347;
RX PubMed=7751322;
RX PubMed=8347478;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx159
AC CVCL_Y054
DR Cosmic; 687512
RX PubMed=12068308;
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HX160c
AC CVCL_L444
SY HX160; HX/160
RX PubMed=2441858;
RX PubMed=8347478;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx163
AC CVCL_Y055
DR Cosmic; 687949
RX PubMed=12068308;
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HX165c
AC CVCL_N849
SY HX 165c
RX PubMed=3179184;
CC Doubling time: 38 hours (PubMed=3179184).
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hx169
AC CVCL_Y056
DR Cosmic; 687950
RX PubMed=12068308;
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HX170c
AC CVCL_N850
SY Hx170c
DR Cosmic; 687951
RX PubMed=2930681;
RX PubMed=12068308;
RX PubMed=23882450;
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HX171c
AC CVCL_M690
SY HX171; HX/171; HX/171c
RX PubMed=2475347;
RX PubMed=8347478;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HX2
AC CVCL_Y021
RX PubMed=19833967;
CC Group: Fish cell line.
CC Group: Haploid karyotype cell line.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Female
CA Embryonic stem cell
//
ID Hx29
AC CVCL_Y057
DR Cosmic; 687987
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HX3
AC CVCL_Y022
RX PubMed=19833967;
CC Group: Fish cell line.
CC Group: Haploid karyotype cell line.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Female
CA Embryonic stem cell
//
ID Hx34
AC CVCL_H763
SY HX34
DR Cosmic; 688049
RX PubMed=12068308;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx39
AC CVCL_Y058
DR Cosmic; 688041
RX PubMed=12068308;
DI NCIt; C3877; Testicular teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hx53
AC CVCL_Y059
DR Cosmic; 687967
RX PubMed=12068308;
DI NCIt; C7328; Testicular seminoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Hx55
AC CVCL_Y060
DR Cosmic; 687522
RX PubMed=12068308;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx60
AC CVCL_Y061
DR Cosmic; 688099
RX PubMed=12068308;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Hx62-26
AC CVCL_Y036
SY Hx62/26; HX62-26
DR Cosmic; 724836
DR Cosmic; 1609536
RX PubMed=12068308;
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4995 ! HX/62
SX Female
CA Cancer cell line
//
ID Hx71
AC CVCL_Y062
DR Cosmic; 687988
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx72
AC CVCL_Y063
DR Cosmic; 687989
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx74
AC CVCL_Y064
DR Cosmic; 687990
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx78
AC CVCL_Y065
DR Cosmic; 687991
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx81
AC CVCL_Y066
DR Cosmic; 687992
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx83
AC CVCL_Y067
DR Cosmic; 687785
RX PubMed=12068308;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx87
AC CVCL_Y068
DR Cosmic; 687597
RX PubMed=12068308;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx88
AC CVCL_Y069
DR Cosmic; 687993
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx90
AC CVCL_Y070
DR Cosmic; 687598
RX PubMed=12068308;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx93
AC CVCL_Y071
DR Cosmic; 687599
RX PubMed=12068308;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx94
AC CVCL_Y072
DR Cosmic; 724862
RX PubMed=12068308;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Hx96
AC CVCL_Y073
DR Cosmic; 687994
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxAC4
AC CVCL_Y074
DR Cosmic; 687523
RX PubMed=12068308;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxEC4
AC CVCL_Y075
DR Cosmic; 687524
RX PubMed=12068308;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxGC3
AC CVCL_Y076
DR Cosmic; 687525
RX PubMed=12068308;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HxGo
AC CVCL_Y077
DR Cosmic; 688035
RX PubMed=12068308;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxHC1
AC CVCL_Y078
DR Cosmic; 687526
RX PubMed=12068308;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxLe
AC CVCL_X163
DR Cosmic; 688050
RX PubMed=12068308;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxLL
AC CVCL_X164
DR Cosmic; 687437
RX PubMed=12068308;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxLo
AC CVCL_Y079
DR Cosmic; 687489
RX PubMed=12068308;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HxMm
AC CVCL_X165
DR Cosmic; 688051
RX PubMed=12068308;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxMu
AC CVCL_Y080
DR Cosmic; 687513
RX PubMed=12068308;
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HXO-Rb44
AC CVCL_D542
SY HXO-RB44
DR ChEMBL-Cells; CHEMBL3307832
DR ChEMBL-Targets; CHEMBL613981
RX PubMed=8575599;
RX PubMed=22553703;
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HxURC
AC CVCL_Y081
DR Cosmic; 687527
RX PubMed=12068308;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HxWe
AC CVCL_Y082
DR Cosmic; 687968
RX PubMed=12068308;
DI NCIt; C7328; Testicular seminoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HY0003
AC CVCL_8X67
DR ECACC; 97102205
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HY0007
AC CVCL_8X68
DR ECACC; 98090202
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HY3-11.27
AC CVCL_J126
DR CLO; CLO_0004311
DR ATCC; HB-8116
RX Patent=US4511661;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HY595
AC CVCL_Y286
DR IMGT/HLA; 10784
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Hybridoma 231
AC CVCL_L524
SY 231
DR CLO; CLO_0004312
DR ATCC; HB-9401
RX Patent=US5169775;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Hybridoma 234
AC CVCL_L525
SY Hybridoma 234 s.1; 234(1)
DR CLO; CLO_0004313
DR ATCC; HB-9402
RX Patent=US5169775;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Hybridoma 234 s.2a
AC CVCL_L526
SY 234(2a)
DR CLO; CLO_0004314
DR ATCC; HB-9403
RX Patent=US5169775;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Hybridoma cell line 23
AC CVCL_N459
SY Hybridoma 23
DR ATCC; HB-8630
RX Patent=US4707438;
CC Discontinued: ATCC; HB-8630; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID HyGPD-YK-1-1
AC CVCL_L551
SY HyGPD.YK-1-1
DR CLO; CLO_0050287
DR ECACC; 92120704
DR RCB; RCB0711
CC Monoclonal antibody target: UniProtKB; P46406; Rabbit GAPDH.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID HYKO6
AC CVCL_F752
RX PubMed=15696577;
CC Knockout cell: Method=KO mouse; MGI; MGI:1340806; Parp1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID HYKSSPC
AC CVCL_W382
RX PubMed=17257376;
CC Doubling time: 51.4 hours (PubMed=17257376).
CC Derived from metastatic site: Ascites.
DI NCIt; C4182; Serous surface papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HyLDH-YK-1
AC CVCL_L552
SY HyLDH.YK-1
DR CLO; CLO_0050303
DR RCB; RCB0709
CC Monoclonal antibody target: UniProtKB; P13491; Rabbit LDHA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID HyLDH-YK-2
AC CVCL_L553
SY HyLDH.YK-2
DR CLO; CLO_0050285
DR RCB; RCB0710
CC Monoclonal antibody target: UniProtKB; P13491; Rabbit LDHA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID HYMEQ-1
AC CVCL_5293
RX PubMed=12662435;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID HYMEQ-5
AC CVCL_5294
RX PubMed=12662435;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HYMEQ-5
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID HYMEQ-8
AC CVCL_5295
RX PubMed=12662435;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID HYON
AC CVCL_IN53
RX PubMed=6230491;
CC Doubling time: 36 hours (PubMed=3262645).
DI NCIt; C3168; Childhood acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HYT-1
AC CVCL_4639
DR CLO; CLO_0051543
DR BioSample; SAMN03472127
DR RCB; RCB1297
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 9
ST D13S317: 8,10
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HYVC
AC CVCL_S743
RX PubMed=12889856;
CC Doubling time: 41-43 hours (PubMed=12889856).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HZ-293TS
AC CVCL_1H36
DR ATCC; PTA-10165
RX Patent=US8236527;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
CC Discontinued: ATCC; PTA-10165; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID I 2.1
AC CVCL_3724
SY I2.1; I2-1
DR CLO; CLO_0004316
DR ATCC; CRL-2572
DR BioSample; SAMN03471680
DR CCRID; 3111C0001CCC000241
RX PubMed=10616904;
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1061 ! A3
SX Male
CA Cancer cell line
//
ID I 3
AC CVCL_C376
SY I3; TE03; TE-03; ES-I3; TECHe001-A
DR EFO; EFO_0007076
DR BioSample; SAMN03471893
DR ENCODE; ENCBS057COO
DR ENCODE; ENCBS058LJQ
DR ENCODE; ENCBS065EQG
DR ENCODE; ENCBS224XQX
DR ENCODE; ENCBS268NCC
DR ENCODE; ENCBS312JDV
DR ENCODE; ENCBS401QZO
DR ENCODE; ENCBS412HHB
DR ENCODE; ENCBS421TWG
DR ENCODE; ENCBS433JWB
DR ENCODE; ENCBS524MEF
DR ENCODE; ENCBS533SYQ
DR ENCODE; ENCBS593HOC
DR ENCODE; ENCBS599JGY
DR ENCODE; ENCBS682JTI
DR ENCODE; ENCBS811OSD
DR GEO; GSM537624
DR GEO; GSM537625
DR GEO; GSM537626
DR GEO; GSM537627
DR GEO; GSM537647
DR GEO; GSM537648
DR GEO; GSM537664
DR GEO; GSM537665
DR GEO; GSM537668
DR GEO; GSM537669
DR GEO; GSM537670
DR GEO; GSM537672
DR GEO; GSM621345
DR GEO; GSM621348
DR GEO; GSM621386
DR GEO; GSM772789
DR GEO; GSM856736
DR GEO; GSM981282
DR GEO; GSM981293
DR hPSCreg; TECHe001-A
DR IGRhCellID; I3%20p41
DR ISCR; 121
RX PubMed=16919167;
RX PubMed=17572666;
RX PubMed=23117585;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=528
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/te03.cmsx
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=8
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0204.
CC Registration: Swiss research registry; BAG-hES-IMP-0005.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=16919167; WiCell
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID I 3.2
AC CVCL_C377
SY I3.2; TE32; TECHe001-A-1
DR hPSCreg; TECHe001-A-1
DR IGRhCellID; I3.2%20p55
DR ISCR; 119
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C376 ! I 3
SX Female
CA Embryonic stem cell
//
ID I 3.3
AC CVCL_C378
SY I3.3; TE33; TECHe001-A-2
DR hPSCreg; TECHe001-A-2
DR ISCR; 120
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C376 ! I 3
SX Female
CA Embryonic stem cell
//
ID I 4
AC CVCL_C379
SY I4; TE04; TE-04; TECHe002-A
DR GEO; GSM856735
DR hPSCreg; TECHe002-A
DR ISCR; 122
RX PubMed=16919167;
RX PubMed=23117585;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=530
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/te04.cmsx
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=42
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0205.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=16919167; WiCell
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14 (PubMed=16919167)
ST D13S317: 12,14,15 (WiCell)
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 12,13
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID I 6
AC CVCL_C380
SY I6; TE06; TE-06; I6 p50; TECHe003-A
DR BioSample; SAMN03471894
DR GEO; GSM856737
DR hPSCreg; TECHe003-A
DR IGRhCellID; I6%20p50
DR ISCR; 124
RX PubMed=16919167;
RX PubMed=17572666;
RX PubMed=23117585;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=531
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/te06.cmsx
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=9
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0206.
CC Registration: Swiss research registry; BAG-hES-IMP-0004.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=16919167; WiCell
ST Amelogenin: X,Y
ST CSF1PO: 10,11 (PubMed=16919167)
ST CSF1PO: 11 (WiCell)
ST D13S317: 8,11,12 (PubMed=16919167_passage_P44)
ST D13S317: 8,11 (PubMed=16919167_passage_P47)
ST D16S539: 9,13
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 8,9.3
ST TPOX: 10,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID I 6.2
AC CVCL_C381
SY I6.2; TE62; TECHe003-A-1
DR hPSCreg; TECHe003-A-1
DR ISCR; 123
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C380 ! I 6
SX Male
CA Embryonic stem cell
//
ID I 9.2
AC CVCL_3725
SY I9.2; I9-2; I-9-2
DR BTO; BTO:0003683
DR CLO; CLO_0004317
DR ATCC; CRL-2571
DR BioSample; SAMN03471679
DR GEO; GSM1669925
RX PubMed=10616904;
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC Omics: DNA methylation analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,9.2
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1061 ! A3
SX Male
CA Cancer cell line
//
ID I-10
AC CVCL_3527
SY I 10
DR CLO; CLO_0004315
DR CLO; CLO_0004320
DR CLDB; cl1786
DR CLDB; cl1787
DR ATCC; CCL-83
DR ECACC; 89031605
DR IZSLER; BS TCL 28
DR JCRB; JCRB9097
RX PubMed=4288399;
CC Breed/subspecies: BALB/cJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID I-10/DDPh
AC CVCL_HF54
RX PubMed=26714911;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: BALB/cJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3527 ! I-10
SX Male
CA Cancer cell line
//
ID I-10/DDPi
AC CVCL_HF53
RX PubMed=26714911;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: BALB/cJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3527 ! I-10
SX Male
CA Cancer cell line
//
ID I-11.15
AC CVCL_6406
DR CLO; CLO_0004322
DR ATCC; CRL-2470
RX PubMed=1707081;
CC Characteristics: CSF1 dependent.
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Factor-dependent cell line
//
ID I-13.35
AC CVCL_6407
DR CLO; CLO_0004323
DR ATCC; CRL-2471
RX PubMed=1707081;
CC Characteristics: CSF1 dependent.
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Factor-dependent cell line
//
ID I-45
AC CVCL_M200
SY 1-45
CC From: Testa J.; Fox Chase Cancer Center; Philadelphia; USA.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID I-45-BTZ-R
AC CVCL_M201
RX PubMed=20482802;
CC Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M200 ! I-45
CA Cancer cell line
//
ID I/24.D6
AC CVCL_9181
SY I/24
DR CLO; CLO_0004319
DR ATCC; HB-251
RX PubMed=1370168;
CC Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID I(TL.m9)
AC CVCL_L527
SY I (TL.m9)
DR CLO; CLO_0004318
DR ATCC; HB-131
RX PubMed=7106865;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID I1-12C
AC CVCL_9S80
RX PubMed=26246272;
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID I1-Hybridoma
AC CVCL_G654
DR CLO; CLO_0004325
DR ATCC; CRL-2700
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID i10984
AC CVCL_IJ10
RX PubMed=27789402;
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4M53 ! AG10984
SX Female
CA Induced pluripotent stem cell
//
ID I11
AC CVCL_2H89
SY I11/GrsrJ; C57BL/6J-Chr 1A/J/NaJ I11/GrsrJ
WW http://jaxmice.jax.org/strain/022089.html
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID i11001
AC CVCL_IJ11
RX PubMed=27789405;
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4M57 ! AG11001
SX Female
CA Induced pluripotent stem cell
//
ID I2-12F
AC CVCL_DQ92
RX PubMed=27345971;
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID I21
AC CVCL_2H90
SY I21/GrsrJ; C57BL/6J-Chr 2A/J/NaJ I21/GrsrJ
WW http://jaxmice.jax.org/strain/022090.html
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID I27
AC CVCL_2H91
SY I27/GrsJ; C57BL/6J-Chr 3A/J/NaJ I27/GrsJ
WW http://jaxmice.jax.org/strain/022091.html
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID I3-iPSC
AC CVCL_DD60
SY I03-iPSC
RX PubMed=25843045;
RX PubMed=27191603;
ST Source(s): PubMed=27191603
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 11,12
ST D21S11: 29
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 14,17
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y811 ! ND29543
SX Male
CA Induced pluripotent stem cell
//
ID I3/2
AC CVCL_DC75
RX PubMed=78961;
CC Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4696 ! S194/5.XXO.BU.1
CA Hybridoma
//
ID I51T
AC CVCL_5530
DR JCRB; JCRB1225
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E938 ! SV
CA Transformed cell line
//
ID I78
AC CVCL_2H92
SY I78/GrsrJ; C57BL/6J-Chr 6A/J/NaJ I78/GrsrJ
WW http://jaxmice.jax.org/strain/025644.html
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID I83-E95
AC CVCL_Y437
SY 183-E95; I83E95
DR DSMZ; ACC-763
DR NCBI_Iran; C492
RX PubMed=8127151;
RX PubMed=23297799;
CC Doubling time: ~30-60 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 9.3,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y546 ! I83-LCL
SX Male
CA Transformed cell line
//
ID I83-LCL
AC CVCL_Y546
DR DSMZ; ACC-764
RX PubMed=8127151;
RX PubMed=23297799;
CC Doubling time: ~40-50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y437 ! I83-E95
SX Male
CA Transformed cell line
//
ID Ia-270
AC CVCL_0T74
RX PubMed=3978245;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IA-5
AC CVCL_6658
DR CLO; CLO_0050074
DR BioSample; SAMN03472288
DR RCB; RCB0548
RX PubMed=22576795;
CC Derived from metastatic site: Skin.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 10
ST D5S818: 10,11
ST D7S820: 8,12
ST TH01: 9
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1302 ! IA-LM
SX Male
CA Cancer cell line
//
ID IA-LM
AC CVCL_1302
SY IALM
DR CLO; CLO_0050075
DR BioSample; SAMN03472289
DR CCLE; IALM_LUNG
DR ChEMBL-Cells; CHEMBL3308833
DR ChEMBL-Targets; CHEMBL2366366
DR Cosmic; 910779
DR Cosmic; 1995452
DR Cosmic-CLP; 910779
DR GDSC; 910779
DR GEO; GSM887156
DR GEO; GSM888228
DR GEO; GSM1669926
DR LINCS; 50017
DR RCB; RCB0554
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 10,11
ST D5S818: 10,11
ST D7S820: 8,12
ST TH01: 9
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6658 ! IA-5
SX Male
CA Cancer cell line
//
ID IA-XsSBR
AC CVCL_3528
SY IA-Xs SBR
DR CLO; CLO_0004327
DR CLO; CLO_0004328
DR CLDB; cl1793
DR ATCC; CRL-1677
DR ChEMBL-Cells; CHEMBL3308400
DR ChEMBL-Targets; CHEMBL614007
DR ECACC; 88090801
RX PubMed=904002;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: Holtzman Sprague-Dawley.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID IA1-7
AC CVCL_6G75
RX PubMed=1714402;
CC Transfected with: HGNC; 2438; CSF3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID IAC
AC CVCL_X373
SY Immortalized Astrocyte Cells
RX DOI=10.3760/j.issn:0254-1416.2004.11.010;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID IAC/hPPE
AC CVCL_0U76
RX PubMed=18045517;
CC Transfected with: HGNC; 8831; PENK.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_X373 ! IAC
CA Transformed cell line
//
ID IAL-PID2
AC CVCL_Z393
SY PID2
RX DOI=10.1016/0022-1910(83)90026-4;
RX PubMed=1561320;
RX PubMed=16593348;
CC Group: Insect cell line.
OX NCBI_TaxID=58824; ! Plodia interpunctella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IAL-SFD1
AC CVCL_Z392
RX DOI=10.1016/0022-1910(83)90026-4;
CC Group: Insect cell line.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IAL-TND1
AC CVCL_Z391
RX PubMed=12623313;
RX PubMed=15926859;
RX PubMed=16593180;
WW http://www.ars.usda.gov/SP2UserFiles/person/3489/TND1.pdf
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID iAN1
AC CVCL_EQ30
SY iPSC_AN1; Normal iPSC from AN1
DR GEO; GSM1184274
DR GEO; GSM1184275
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iAN2
AC CVCL_EQ31
SY iPSC_AN2; Normal iPSC from AN2
DR GEO; GSM1184276
DR GEO; GSM1184277
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iAN3
AC CVCL_EQ32
SY iPSC_AN3; Normal iPSC from AN3
DR GEO; GSM1184278
DR GEO; GSM1184279
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iAND-4
AC CVCL_K225
SY iAND4; AND-4
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud_Deposito_AND-4.pdf
CC From: Andalusian Stem Cell Bank; Granada; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IAR 2
AC CVCL_J447
SY IAR-2; IAR2
RX PubMed=1176206;
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID IAR 2-19
AC CVCL_D608
SY IAR-2-19; IAR2-19
RX PubMed=1176206;
RX PubMed=6288280;
CC Transformant: ChEBI; CHEBI:35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC Misspelling: 'IAR-19' in abstract of PubMed=6288280.
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_J447 ! IAR 2
CA Transformed cell line
//
ID IAR 2-28
AC CVCL_D611
SY IAR-2-28; IAR2-28
RX PubMed=1176206;
RX PubMed=6288280;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Misspelling: 'IAR-28' in abstract of PubMed=6288280.
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_J447 ! IAR 2
CA Transformed cell line
//
ID IAR 20
AC CVCL_5296
SY IAR-20; IAR20
DR CCRID; 3111C0001CCC000142
DR JCRB; JCRB0610
RX PubMed=3013663;
RX PubMed=3402047;
RX PubMed=6288280;
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID IAR 27
AC CVCL_HF37
SY IAR-27; IAR27
RX PubMed=3013663;
RX PubMed=6288280;
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID IAR 27E
AC CVCL_D609
SY IAR 27 E; IAR27E
RX PubMed=3013663;
RX PubMed=3402047;
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_HF37 ! IAR 27
CA Spontaneously immortalized cell line
//
ID IAR 27F
AC CVCL_D610
SY IAR 27 F; IAR27F
RX PubMed=3013663;
RX PubMed=3402047;
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_HF37 ! IAR 27
CA Spontaneously immortalized cell line
//
ID IAR 6
AC CVCL_D612
SY IAR-6; IAR6
RX PubMed=1176206;
RX PubMed=7042722;
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID IAR 6-1
AC CVCL_D613
SY IAR-6-1; IAR6-1; IAR 6.1
RX PubMed=1176206;
RX PubMed=3013663;
RX PubMed=3402047;
RX PubMed=6288280;
RX PubMed=7042722;
CC Transformant: ChEBI; CHEBI:35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_D612 ! IAR 6
CA Transformed cell line
//
ID IAR 6-7
AC CVCL_D614
SY IAR-6-7; IAR6-7
RX PubMed=1176206;
RX PubMed=7042722;
CC Breed/subspecies: BDVI.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_D612 ! IAR 6
CA Spontaneously immortalized cell line
//
ID IARC-100
AC CVCL_IW33
SY IARC 100; IARC100
RX PubMed=6327071;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IARC-139
AC CVCL_IV21
SY IARC 139; IARC139; Iarc139
RX PubMed=9473234;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IARC-151
AC CVCL_IV09
SY IARC 151; IARC151
RX PubMed=10997876;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M643 ! BL-47
SX Male
CA Transformed cell line
//
ID IARC-171
AC CVCL_IV22
SY IARC 171; IARC171; Iarc171
RX PubMed=9473234;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IARC-174
AC CVCL_IV23
SY IARC 174; IARC174; Iarc174
RX PubMed=9473234;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IARC-176
AC CVCL_IV05
SY IARC 176; IARC176; IARC176A; IARC 176 B
RX PubMed=2052620;
RX PubMed=3035497;
RX PubMed=6087353;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C147 ! BL-37
SX Male
CA Transformed cell line
//
ID IARC-247
AC CVCL_IV19
SY IARC 247; IARC247
RX PubMed=6087353;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M645 ! BL-54
OI CVCL_M568 ! BL-59
SX Male
CA Transformed cell line
//
ID IARC-261
AC CVCL_IV17
SY IARC 261; IARC261
RX PubMed=3035497;
RX PubMed=6087353;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7034 ! BL-60
OI CVCL_IV06 ! IARC-277
SX Female
CA Transformed cell line
//
ID IARC-277
AC CVCL_IV06
SY IARC 277; IARC277
RX PubMed=2052620;
RX PubMed=3035497;
RX PubMed=6087353;
RX PubMed=10997876;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7034 ! BL-60
OI CVCL_IV17 ! IARC-261
SX Female
CA Transformed cell line
//
ID IARC-290B
AC CVCL_IV08
SY IARC290B
RX PubMed=10997876;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C158 ! BL-74
SX Female
CA Transformed cell line
//
ID IARC-304
AC CVCL_IV28
SY IARC 304; IARC304
RX PubMed=3004968;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1966 ! BL-2
SX Male
CA Transformed cell line
//
ID IARC-306
AC CVCL_IU91
SY IARC 306; IARC306
RX PubMed=1395095;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IARC-307
AC CVCL_IV24
SY IARC 307; IARC307; Iarc307
RX PubMed=9473234;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IARC-309
AC CVCL_IV27
SY IARC 309; IARC309
RX PubMed=3004968;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C156 ! BL-67
CA Transformed cell line
//
ID IARC-317
AC CVCL_IU92
SY IARC 317; IARC317
RX PubMed=1395095;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IARC-318
AC CVCL_IU84
SY IARC 318; IARC.318; IARC318
DR Cosmic; 2491067
RX PubMed=1395095;
RX PubMed=8381152;
RX PubMed=9067587;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IARC-385
AC CVCL_IV11
SY IARC 385; IARC385
RX PubMed=10997876;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C165 ! BL-79
CA Transformed cell line
//
ID IARC-518
AC CVCL_IU90
SY IARC 518; IARC.518; IARC518
RX PubMed=1395095;
RX PubMed=8381152;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IARC-549
AC CVCL_IV10
SY IARC 549; IARC549
RX PubMed=10997876;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M556 ! BL-61
OI CVCL_C155 ! BL-64
SX Male
CA Transformed cell line
//
ID IARC-582
AC CVCL_IU93
SY IARC 582; IARC582
RX PubMed=1395095;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IARC-629
AC CVCL_IV18
SY IARC 629; IARC629
RX PubMed=3035497;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IU51 ! BL-104
CA Transformed cell line
//
ID IARC-632
AC CVCL_IV07
SY IARC 632; IARC632
RX PubMed=2052620;
RX PubMed=10997876;
CC From: Lenoir G.M.; International Agency of Research on Cancer (IARC); Lyon; France.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C132 ! BL-113
CA Transformed cell line
//
ID IB C1 (clon A201)
AC CVCL_9S13
SY IBC1; BP143 clon A201; BP143 A201
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud-de-deposito-IB-C1.pdf
CC From: Inbiomed; Gipuzkoa; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IB PD-G1
AC CVCL_9S14
SY FH10-54 B21
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Ib_pd_g1.pdf
CC From: Inbiomed; Gipuzkoa; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IB PD-G2
AC CVCL_9S15
SY FH09-32 A4001
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Ib_pd_g2.pdf
CC From: Inbiomed; Gipuzkoa; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IB PD-I1
AC CVCL_9S16
SY IB-PDI1; FH10-70 B41
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/IB_pdi1.pdf
CC From: Inbiomed; Gipuzkoa; Spain.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IB SvC1
AC CVCL_9S17
SY IB SVC1
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud-de-deposito-IB-SvC1.pdf
CC From: Inbiomed; Gipuzkoa; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IB-9
AC CVCL_0J49
SY IB9; T10 clone IB9; 1B9
RX PubMed=2529426;
RX PubMed=7432518;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID IB-RS-2
AC CVCL_4528
SY IBRS-2; IBRS2; Instituto Biologico-Rim Suino-2
DR CLO; CLO_0004332
DR CLDB; cl1794
DR CLDB; cl1795
DR CCLV; CCLV-RIE 0103
DR CCRID; 3142C0001000000022
DR ECACC; 84100503
DR IZSLER; BS CL 51
DR RCB; RCB0532
DR TOKU-E; 4142
RX CelloPub=CLPUB00054;
CC Discontinued: ECACC; 84100503; true.
CC Discontinued: RCB; RCB0532; true.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Spontaneously immortalized cell line
//
ID IB-RS-2 clone 17
AC CVCL_U235
SY IB-RS-2 C-17; IB-RS-2 C17
DR BCRJ; 0340
RX PubMed=2840431;
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_4528 ! IB-RS-2
SX Female
CA Spontaneously immortalized cell line
//
ID IB-RS-2 clone 60
AC CVCL_IP69
RX PubMed=4329431;
CC Doubling time: ~48 hours (PubMed=4329431).
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_4528 ! IB-RS-2
SX Female
CA Spontaneously immortalized cell line
//
ID IB-RS-2 D10
AC CVCL_4529
SY IB-RS-2 clone D10; IBRS-2 D10
DR CLO; CLO_0004333
DR CLDB; cl1796
DR ATCC; CRL-1835
DR IZSLER; BS CL 97
RX PubMed=2840431;
CC Discontinued: ATCC; CRL-1835; true.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_U235 ! IB-RS-2 clone 17
SX Female
CA Spontaneously immortalized cell line
//
ID IB3-1
AC CVCL_0338
SY IB3
DR BTO; BTO:0004445
DR CLO; CLO_0004329
DR EFO; EFO_0001194
DR MCCL; MCC:0000234
DR ATCC; CRL-2777
DR ATCC; JHU-52
DR BCRJ; 0114
RX PubMed=1380129;
RX PubMed=1849726;
RX PubMed=7679117;
RX PubMed=15463957;
RX PubMed=16512671;
RX PubMed=18441018;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-527.html
CC Characteristics: Heterozygous for the CFTR p.Phe508del and p.Trp1282Ter mutations.
CC Transformant: Ad12-SV40.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Discontinued: ATCC; CRL-2777; true.
CC Discontinued: ATCC; JHU-52; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,12,13
ST D16S539: 9,11
ST D5S818: 11,12,13
ST D7S820: 11,12
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IB3-1/C38
AC CVCL_4462
SY C38
DR BTO; BTO:0004447
DR CLO; CLO_0002118
DR ATCC; CRL-2779
DR ATCC; JHU-54
DR BioSample; SAMN03471787
RX PubMed=1380129;
RX PubMed=7679117;
RX PubMed=18441018;
CC Transfected with: HGNC; 1884; CFTR.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: Ad12-SV40.
CC Discontinued: ATCC; CRL-2779; true.
CC Discontinued: ATCC; JHU-54; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,12,13
ST D16S539: 9,11
ST D5S818: 11,12,13
ST D7S820: 11,12
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0338 ! IB3-1
SX Male
CA Transformed cell line
//
ID IB3-1/S9
AC CVCL_4461
SY S9
DR BTO; BTO:0004446
DR CLO; CLO_0008935
DR ATCC; CRL-2778
DR ATCC; JHU-53
DR BioSample; SAMN03471786
DR ChEMBL-Cells; CHEMBL3307435
DR ChEMBL-Targets; CHEMBL614892
RX PubMed=1380129;
RX PubMed=15463957;
CC Transfected with: HGNC; 1884; CFTR.
CC Transformant: Ad12-SV40.
CC Discontinued: ATCC; CRL-2778; true.
CC Discontinued: ATCC; JHU-53; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,12,13
ST D16S539: 9,11
ST D5S818: 11,12,13
ST D7S820: 11,12
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0338 ! IB3-1
SX Male
CA Transformed cell line
//
ID IB4
AC CVCL_0339
DR CLO; CLO_0004330
DR MCCL; MCC:0000235
DR ATCC; HB-10164
RX Patent=US5147637;
CC Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID iBC
AC CVCL_EQ33
SY iPSC_BC; Normal iPSC from BC
DR GEO; GSM1184280
DR GEO; GSM1184281
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IBE
AC CVCL_M956
RX PubMed=8838868;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IBEP-1
AC CVCL_G209
DR GEO; GSM217582
RX PubMed=9610725;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IBEP-2
AC CVCL_0340
SY IBEP2
DR MCCL; MCC:0000236
RX PubMed=9610725;
RX PubMed=15218360;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IBEP-3
AC CVCL_G210
RX PubMed=9610725;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IBH-4
AC CVCL_M356
RX PubMed=15095293;
RX PubMed=19194992;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IBH-6
AC CVCL_M357
RX PubMed=15095293;
RX PubMed=19194992;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IBH-7
AC CVCL_M358
RX PubMed=15095293;
RX PubMed=19194992;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IBHK-4
AC CVCL_W219
WW http://www.incell.com/wp-content/files/IBHK-4_Cell_Line_Product_Information_Sheet_INCELL_2016.pdf
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID IBL-1
AC CVCL_9638
SY IBL1
RX PubMed=18230756;
DI NCIt; C8285; AIDS related immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IBL-4
AC CVCL_9639
SY IBL4
DR EFO; EFO_0002060
DR BioSamples; SAMEA365964
DR BioSamples; SAMEA365976
DR GEO; GSM38804
DR GEO; GSM38805
RX DOI=10.1186/1742-4690-3-S1-P24;
RX PubMed=10554028;
RX PubMed=15613351;
RX PubMed=18230756;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C8285; AIDS related immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IBL-SLO-1A
AC CVCL_Z346
SY IBL-SLO1A; IBL-SL1A; SL1A
RX PubMed=9028921;
CC Group: Insect cell line.
OX NCBI_TaxID=69820; ! Spodoptera litura
SX Female
CA Spontaneously immortalized cell line
//
ID IBL-SLO-7A
AC CVCL_Z345
SY SL7A
RX CelloPub=CLPUB00175;
CC Group: Insect cell line.
CC Doubling time: 21.4 hours (CelloPub=CLPUB00175).
OX NCBI_TaxID=69820; ! Spodoptera litura
SX Female
CA Spontaneously immortalized cell line
//
ID iBM5
AC CVCL_B942
DR ISCR; 1438
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iBM9
AC CVCL_B943
DR ISCR; 1439
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IBMS-iPSC-01-02
AC CVCL_GT27
DR BCRC; SC81036
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IBMS-iPSC-02-07
AC CVCL_GT28
SY IBMS-iPS-02-07
DR BCRC; SC81031
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IBW4
AC CVCL_F525
SY IBw4; GM03104
DR CLO; CLO_0013566
DR Coriell; GM03104
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IBW9
AC CVCL_E706
SY IBw9; GM08065
DR CLO; CLO_0010028
DR Coriell; GM08065
DR dbMHC; 48902
DR ECACC; 85052104
DR IHW; IHW9049
DR IMGT/HLA; 11634
WW http://bioinformatics.hsanmartino.it/ecbr/cl49.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; GM08065; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IC-01
AC CVCL_L845
SY O1
DR ECACC; 93042001
RX PubMed=6786942;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IC-04
AC CVCL_Z932
SY O4
DR ECACC; 93042002
RX PubMed=6786942;
CC Discontinued: ECACC; 93042002; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IC-07
AC CVCL_L846
DR ECACC; 93062301
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IC-08
AC CVCL_L847
DR ECACC; 93062302
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IC-09
AC CVCL_L848
DR ECACC; 93062303
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IC-2
AC CVCL_0341
SY IC2
DR CLO; CLO_0050771
DR MCCL; MCC:0000237
DR RCB; RCB0102
RX PubMed=2580015;
RX PubMed=3079807;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=IC-2
CC Characteristics: CSF2 and IL3 dependent.
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Factor-dependent cell line
//
ID IC-21
AC CVCL_3726
SY IC21; TM; Transformed macrophage
DR BTO; BTO:0000806
DR CLO; CLO_0004334
DR CLDB; cl1797
DR ATCC; TIB-186
RX PubMed=1167563;
RX PubMed=1254971;
RX PubMed=4357034;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
WW http://genepath.med.harvard.edu/bdlab/labprotocols/ic21.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID iC(3)-1
AC CVCL_M689
SY Induced choriocarcinoma cell-1
RX PubMed=21787741;
RX PubMed=23199791;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7162 ! HTR-8/SVneo
SX Sex undetermined
CA Transformed cell line
//
ID IC441
AC CVCL_EP78
RX PubMed=14647443;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IC52
AC CVCL_EP79
RX PubMed=14647443;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IC692
AC CVCL_EP80
RX PubMed=14647443;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IC954
AC CVCL_EP81
RX PubMed=14647443;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ICB-104
AC CVCL_W328
RX PubMed=11004677;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ICB-112
AC CVCL_1H29
SY ICB 112
RX PubMed=7798952;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID iCB5
AC CVCL_C958
DR ISCR; 1440
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID ICBD-1
AC CVCL_L093
RX CelloPub=CLPUB00275;
RX PubMed=9468580;
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ICF
AC CVCL_M423
SY Indian Catfish Fin
RX PubMed=21401643;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=22
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC022.
OX NCBI_TaxID=59899; ! Clarias batrachus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ICG
AC CVCL_1G91
SY Indian Catla Gill
RX PubMed=23237299;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=21
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC021.
OX NCBI_TaxID=72446; ! Gibelion catla
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ICH-ERMS-1
AC CVCL_EG67
DR JCRB; JCRB1648
RX PubMed=23578105;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID iCK10
AC CVCL_Y698
SY A000049#10; A000049# 10
DR RCB; HPS0085
DR SKIP; SKIP000030
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4726 ! NCU-F10
SX Female
CA Induced pluripotent stem cell
//
ID iCK2
AC CVCL_T827
SY A000049#2; A000049# 2
DR RCB; HPS0083
DR SKIP; SKIP000028
DR SKIP; SKIP000267
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4726 ! NCU-F10
SX Female
CA Induced pluripotent stem cell
//
ID iCK8
AC CVCL_Y697
SY A000049#8; A000049# 8
DR RCB; HPS0084
DR SKIP; SKIP000029
DI NCIt; C9460; Cockayne syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4726 ! NCU-F10
SX Female
CA Induced pluripotent stem cell
//
ID ICR B20
AC CVCL_5G40
RX PubMed=1261610;
RX PubMed=4543150;
WW http://www.osti.gov/scitech/servlets/purl/4623769/
CC Group: Amphibian cell line.
CC Group: Haploid karyotype cell line.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
OX NCBI_TaxID=8404; ! Lithobates pipiens
HI CVCL_4345 ! ICR-2A
CA Spontaneously immortalized cell line
//
ID ICR MEF
AC CVCL_6409
DR CLO; CLO_0004337
DR ATCC; SCRC-1046
CC Discontinued: ATCC; SCRC-1046; true.
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
SX Mixed sex
CA Finite cell line
//
ID ICR-134
AC CVCL_6408
SY ICR 134; ICR134; RPH 67.134c2; RPH67.134c2
DR CLO; CLO_0004336
DR ATCC; CCL-128
RX PubMed=5263768;
RX PubMed=23891577;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8404; ! Lithobates pipiens
CA Spontaneously immortalized cell line
//
ID ICR-2A
AC CVCL_4345
SY ICR 2A; ICR2A; RPH 68.2A; RPH68.2A
DR CLO; CLO_0004338
DR CLDB; cl1800
DR ATCC; CCL-145
DR ECACC; 89072615
DR IZSLER; BS CL 191
RX PubMed=2569015;
RX PubMed=2910704;
RX PubMed=3500873;
RX PubMed=5263768;
WW http://www.osti.gov/scitech/servlets/purl/4607053
CC Group: Amphibian cell line.
CC Group: Haploid karyotype cell line.
OX NCBI_TaxID=8404; ! Lithobates pipiens
CA Spontaneously immortalized cell line
//
ID ICRft-2
AC CVCL_F047
DR RCB; AES0049
DR RCB; RCB2198
CC Discontinued: RCB; RCB2198; true.
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID ICRmt-1
AC CVCL_4E29
DR RCB; RCB2196
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Caution: Not from strain ICR as originally assigned (DOI 10.4051/ibc.2010.2.4.0014).
CC Discontinued: RCB; RCB2196; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID ID00001
AC CVCL_2Z01
DR CLO; CLO_0029274
DR Coriell; ID00001
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3822; X-linked agammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00002
AC CVCL_2Z02
DR CLO; CLO_0029275
DR Coriell; ID00002
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84783; Immunodeficiency with hyper-IgM
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00003
AC CVCL_2Z03
DR CLO; CLO_0029273
DR Coriell; ID00003
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3448; Wiskott-Aldrich syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00004
AC CVCL_2Z04
DR CLO; CLO_0029219
DR Coriell; ID00004
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3448; Wiskott-Aldrich syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00006
AC CVCL_2Z05
DR CLO; CLO_0029221
DR Coriell; ID00006
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00011
AC CVCL_2Z06
DR CLO; CLO_0029223
DR Coriell; ID00011
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00013
AC CVCL_2Z07
DR CLO; CLO_0029224
DR Coriell; ID00013
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00014
AC CVCL_2Z08
DR CLO; CLO_0029227
DR Coriell; ID00014
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00015
AC CVCL_2Z09
DR CLO; CLO_0029229
DR Coriell; ID00015
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00016
AC CVCL_2Z10
DR CLO; CLO_0029230
DR Coriell; ID00016
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00017
AC CVCL_6G82
DR CLO; CLO_0029232
DR Coriell; ID00017
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00018
AC CVCL_4T32
DR CLO; CLO_0029234
DR Coriell; ID00018
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123434; Immunoglobulin A deficiency 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00021
AC CVCL_2Z11
DR CLO; CLO_0029233
DR Coriell; ID00021
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00022
AC CVCL_2Z12
DR CLO; CLO_0029188
DR Coriell; ID00022
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00024
AC CVCL_2Z13
DR CLO; CLO_0029196
DR Coriell; ID00024
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00025
AC CVCL_2Z14
DR CLO; CLO_0029199
DR Coriell; ID00025
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00026
AC CVCL_2Z15
DR CLO; CLO_0029191
DR Coriell; ID00026
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00028
AC CVCL_2Z16
DR CLO; CLO_0029193
DR Coriell; ID00028
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00029
AC CVCL_2Z17
DR CLO; CLO_0029207
DR Coriell; ID00029
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00030
AC CVCL_8B16
DR CLO; CLO_0029210
DR Coriell; ID00030
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85073; Selective antibody deficiency with normal immunoglobulins
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00031
AC CVCL_2Z18
DR CLO; CLO_0029201
DR Coriell; ID00031
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00032
AC CVCL_2Z19
DR CLO; CLO_0029204
DR Coriell; ID00032
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00034
AC CVCL_2Z20
DR CLO; CLO_0029213
DR Coriell; ID00034
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C26725; Common variable immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00035
AC CVCL_2Z21
DR CLO; CLO_0029164
DR Coriell; ID00035
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3822; X-linked agammaglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00036
AC CVCL_4T33
DR CLO; CLO_0029165
DR Coriell; ID00036
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123434; Immunoglobulin A deficiency 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00037
AC CVCL_4T34
DR CLO; CLO_0029175
DR Coriell; ID00037
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00038
AC CVCL_4T35
DR CLO; CLO_0029178
DR Coriell; ID00038
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123434; Immunoglobulin A deficiency 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00044
AC CVCL_2Z22
DR Coriell; ID00044
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00045
AC CVCL_2Z23
DR CLO; CLO_0029180
DR Coriell; ID00045
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2887; Ataxia telangiectasia syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00050
AC CVCL_2Z24
DR CLO; CLO_0029182
DR Coriell; ID00050
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61246; X-linked lymphoproliferative syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00051
AC CVCL_2Z25
DR CLO; CLO_0029167
DR Coriell; ID00051
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61246; X-linked lymphoproliferative syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00052
AC CVCL_2Z26
DR CLO; CLO_0029169
DR Coriell; ID00052
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C4682; X-linked severe combined immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00057
AC CVCL_4T36
DR CLO; CLO_0029171
DR Coriell; ID00057
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C123434; Immunoglobulin A deficiency 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00058
AC CVCL_4T37
DR CLO; CLO_0029174
DR Coriell; ID00058
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00059
AC CVCL_8B17
DR CLO; CLO_0030017
DR Coriell; ID00059
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85073; Selective antibody deficiency with normal immunoglobulins
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00060
AC CVCL_8B14
DR CLO; CLO_0030018
DR Coriell; ID00060
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00061
AC CVCL_8B15
DR CLO; CLO_0030019
DR Coriell; ID00061
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00063
AC CVCL_2Z27
DR Coriell; ID00063
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84783; Immunodeficiency with hyper-IgM
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00064
AC CVCL_2Z28
DR Coriell; ID00064
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84783; Immunodeficiency with hyper-IgM
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00078
AC CVCL_2Z29
DR Coriell; ID00078
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61240; Omenn syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ID00079
AC CVCL_2Z30
DR Coriell; ID00079
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61245; Cartilage hair hypoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID ID00081
AC CVCL_2Z31
DR Coriell; ID00081
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61245; Cartilage hair hypoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID ID00082
AC CVCL_2Z32
DR Coriell; ID00082
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61245; Cartilage hair hypoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID ID00083
AC CVCL_2Z33
DR Coriell; ID00083
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61245; Cartilage hair hypoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID ID00084
AC CVCL_2Z34
DR Coriell; ID00084
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C61245; Cartilage hair hypoplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID00085
AC CVCL_2Z35
DR Coriell; ID00085
CC Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C4682; X-linked severe combined immunodeficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ID8
AC CVCL_IU14
SY ID8/MOSEC
RX PubMed=10753190;
RX PubMed=16886597;
RX PubMed=18036641;
RX PubMed=27235858;
CC Characteristics: ID8 is a mouse ovarian surface epithelium (MOSE) spontaneously transformed cell line that is physiologically and biologically closely resembling human epithelial ovarian cancer.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID ID8-Fluc
AC CVCL_IU15
SY ID8-fluc
RX PubMed=26676113;
CC Characteristics: ID8 is a mouse ovarian surface epithelium (MOSE) spontaneously transformed cell line that is physiologically and biologically closely resembling human epithelial ovarian cancer.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_IU14 ! ID8
SX Female
CA Spontaneously immortalized cell line
//
ID ID8-Luc2
AC CVCL_IU16
SY ID8luc2
RX PubMed=25992288;
RX PubMed=26676113;
RX PubMed=27235858;
CC Characteristics: ID8 is a mouse ovarian surface epithelium (MOSE) spontaneously transformed cell line that is physiologically and biologically closely resembling human epithelial ovarian cancer.
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_IU14 ! ID8
SX Female
CA Spontaneously immortalized cell line
//
ID IDE1
AC CVCL_Z164
RX Patent=US5869335;
RX PubMed=8064520;
CC Group: Tick cell line.
OX NCBI_TaxID=6945; ! Ixodes scapularis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IDE12
AC CVCL_Z165
DR Wikidata; Q28658510
RX Patent=US5869335;
RX PubMed=8057317;
RX PubMed=8064520;
RX PubMed=17662657;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW https://www.vectorbase.org/data/ixodes-scapularis-ide12-cell-line-avcl
CC Group: Tick cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=6945; ! Ixodes scapularis
SX Mixed sex
CA Spontaneously immortalized cell line
//
ID IDE2
AC CVCL_Z166
DR TCB; 3126
RX Patent=US5869335;
RX PubMed=8064520;
RX PubMed=9364140;
RX PubMed=11257184;
RX PubMed=17662657;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW https://www.vectorbase.org/data/ixodes-scapularis-ide2-cell-line-avcl
CC Group: Tick cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=6945; ! Ixodes scapularis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IDE8
AC CVCL_Z167
DR ATCC; CRL-11973
DR TCB; 3041
RX Patent=US5869335;
RX PubMed=8057317;
RX PubMed=8064520;
RX PubMed=8812616;
RX PubMed=15053931;
RX PubMed=17662657;
RX PubMed=20388200;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW https://www.vectorbase.org/data/ixodes-scapularis-ide8-cell-line-avcl
CC Group: Tick cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=6945; ! Ixodes scapularis
SX Mixed sex
CA Spontaneously immortalized cell line
//
ID IDF
AC CVCL_E707
SY GM03105; GM 3105
DR CLO; CLO_0013565
DR Coriell; GM03105
DR dbMHC; 48903
DR ECACC; 94022530
DR IHW; IHW9211
DR IMGT/HLA; 10795
WW http://bioinformatics.hsanmartino.it/ecbr/cl211.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IDG-SW3
AC CVCL_0P23
RX PubMed=21735478;
WW https://www.kerafast.com/product/1781/idg-sw3-bone-cell-line
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IDH4
AC CVCL_3874
SY IMR90-D305.2H4
DR BTO; BTO:0001896
RX PubMed=1330670;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Transformed cell line
//
ID IE-10
AC CVCL_9182
DR CLO; CLO_0004339
DR ATCC; CRL-2462
RX PubMed=3996750;
CC Monoclonal antibody target: UniProtKB; P10761; Mouse Zp3.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IE-3
AC CVCL_9183
DR CLO; CLO_0004340
DR ATCC; CRL-2463
RX PubMed=6699085;
CC Monoclonal antibody target: UniProtKB; P20239; Mouse Zp2.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IEAFEs-1
AC CVCL_Z261
SY IEAFES-1; IAF-ES-1; IAF Es 1
DR NISES; SK0027
RX DOI=10.1007/BF02372282;
CC Group: Insect cell line.
OX NCBI_TaxID=690670; ! Euxoa scandens
SX Female
CA Spontaneously immortalized cell line
//
ID IEB
AC CVCL_W362
SY Indian Etroplus Brain
RX PubMed=22268432;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=43
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC043.
OX NCBI_TaxID=238232; ! Etroplus suratensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IEC-14
AC CVCL_T758
SY IEC 14; IEC14; Intestinal Epithelioid Cell line No. 14
RX PubMed=88453;
CC Breed/subspecies: Charles River Sprague Dawley (CD(SD)).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Finite cell line
//
ID IEC-17
AC CVCL_T759
SY IEC 17; IEC17; Intestinal Epithelioid Cell line No. 17
DR TOKU-E; 4045
RX PubMed=3757038;
RX PubMed=6273638;
CC Breed/subspecies: Charles River Sprague Dawley (CD(SD)).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID IEC-18
AC CVCL_0342
SY IEC 18; IEC18; Intestinal Epithelioid Cell line No. 18
DR BTO; BTO:0004604
DR CLO; CLO_0004341
DR MCCL; MCC:0000238
DR CLDB; cl1801
DR ATCC; CRL-1589
DR BCRC; 60230
DR BCRJ; 0116
DR ECACC; 88011801
DR IZSLER; BS CL 224
DR KCLB; 21589
DR Lonza; 7
DR NCBI_Iran; C528
RX PubMed=6273638;
RX PubMed=22358603;
CC Characteristics: Should undergo at least 20 PDL.
CC Discontinued: IZSLER; BS CL 224; probable.
CC Breed/subspecies: Charles River Sprague Dawley (CD(SD)).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID IEC-6
AC CVCL_0343
SY IEC 6; IEC6; Intestinal Epithelioid Cell line No. 6
DR BTO; BTO:0001497
DR CLO; CLO_0004342
DR CLO; CLO_0050826
DR MCCL; MCC:0000239
DR CLDB; cl1802
DR CLDB; cl1803
DR CLDB; cl5209
DR ATCC; CRL-1592
DR BCRC; 60301
DR BCRJ; 0117
DR CCRID; 3111C0001CCC000110
DR DSMZ; ACC-111
DR ECACC; 88071401
DR IZSLER; BS CL 117
DR KCB; KCB 200720YJ
DR KCLB; 21592
DR Lonza; 980
DR RCB; RCB0993
RX PubMed=88453;
RX PubMed=15463957;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-606.html
CC Characteristics: Capable of at least 10 PDL.
CC Doubling time: ~50 hours (DSMZ).
CC Breed/subspecies: Charles River Sprague Dawley (CD(SD)).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Finite cell line
//
ID IEC-CF7
AC CVCL_6973
DR BTO; BTO:0002579
RX PubMed=7681632;
RX PubMed=15463957;
CC Transfected with: HGNC; 1884; CFTR.
CC Breed/subspecies: Charles River Sprague Dawley (CD(SD)).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0343 ! IEC-6
SX Male
CA Finite cell line
//
ID IEE
AC CVCL_W361
SY Indian Etroplus Eye
RX PubMed=22268432;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=40
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC040.
OX NCBI_TaxID=238232; ! Etroplus suratensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IEG
AC CVCL_W364
SY Indian Etroplus Gill
RX PubMed=22268432;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=42
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC042.
OX NCBI_TaxID=238232; ! Etroplus suratensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IEK
AC CVCL_W363
SY Indian Etroplus Kidney
RX PubMed=22268432;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=41
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC041.
OX NCBI_TaxID=238232; ! Etroplus suratensis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IF6
AC CVCL_6999
SY IF-6; 1F6
DR BTO; BTO:0002802
DR Cosmic; 1181746
RX PubMed=1918136;
RX PubMed=2060184;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IFGCP-F1BA10
AC CVCL_G125
DR CLO; CLO_0004343
DR ATCC; HB-8291
DR BCRC; 60431
RX Patent=US4599306;
CC Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Ig(1a)8.3
AC CVCL_L528
SY 20-8.3
DR CLO; CLO_0004344
DR ATCC; TIB-148
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Ig(4a)10.9
AC CVCL_L529
SY 20-9.10
DR CLO; CLO_0004345
DR ATCC; HB-146
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Ig(5a)7.2
AC CVCL_L530
SY 10-4-22
DR CLO; CLO_0004346
DR ATCC; TIB-97
DR ATCC; TIB-149
CC Discontinued: ATCC; TIB-97; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Ig(5b)6.3
AC CVCL_L531
SY 11-6.3.1
DR CLO; CLO_0004347
DR ATCC; TIB-96
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Ig1.Sk/mu
AC CVCL_S179
DR ATCC; CRL-6259
CC Group: Cetacean cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6259; true.
OX NCBI_TaxID=9725; ! Inia geoffrensis
SX Female
CA Finite cell line
//
ID Ig2.M
AC CVCL_S180
DR ATCC; CRL-6260
CC Group: Cetacean cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6260; true.
OX NCBI_TaxID=9725; ! Inia geoffrensis
OI CVCL_S181 ! Ig2.Sk
SX Sex undetermined
CA Finite cell line
//
ID Ig2.Sk
AC CVCL_S181
DR ATCC; CRL-6261
CC Group: Cetacean cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6261; true.
OX NCBI_TaxID=9725; ! Inia geoffrensis
OI CVCL_S180 ! Ig2.M
SX Sex undetermined
CA Finite cell line
//
ID IgE-14-205
AC CVCL_DC76
DR ATCC; CRL-8009
RX Patent=EP0008092B1;
RX PubMed=703844;
CC Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
CC Discontinued: ATCC; CRL-8009; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID IGEL a2
AC CVCL_K044
SY 15.3
DR CLO; CLO_0004384
DR ATCC; TIB-142
RX PubMed=6790293;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID IGEL b4
AC CVCL_K045
DR CLO; CLO_0004385
DR ATCC; TIB-141
DR BCRC; 60451
RX PubMed=6790293;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID IGF031/85
AC CVCL_U950
DR CLO; CLO_0005024
DR CLDB; cl2029
DI NCIt; C84546; Alkaptonuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID IgG-11H4
AC CVCL_L597
DR CLO; CLO_0006466
DR ATCC; CRL-1936
RX PubMed=2762297;
CC Monoclonal antibody target: UniProtKB; Q07954; Human LRP1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IgG-11H9
AC CVCL_G655
DR CLO; CLO_0006467
DR ATCC; CRL-2213
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-13D3
AC CVCL_0F32
DR ATCC; CRL-2932
CC Discontinued: ATCC; CRL-2932; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C561 ! Sp2/mIL-6
CA Hybridoma
//
ID IgG-15A6
AC CVCL_0F33
DR ATCC; CRL-2933
CC Discontinued: ATCC; CRL-2933; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C561 ! Sp2/mIL-6
CA Hybridoma
//
ID IgG-1B3
AC CVCL_G656
SY anti LRP 85
DR CLO; CLO_0006468
DR ATCC; CRL-1937
RX PubMed=2250029;
CC Monoclonal antibody target: UniProtKB; G1T4Z1; Rabbit LRP1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-1B7
AC CVCL_G666
SY IgG-IB7
DR CLO; CLO_0006480
DR ATCC; CRL-2418
RX PubMed=8419339;
CC Monoclonal antibody target: UniProtKB; Q04631; Rat Fnta.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-1C6
AC CVCL_G657
DR CLO; CLO_0006469
DR ATCC; CRL-2224
CC Monoclonal antibody target: UniProtKB; Q12772; Human SREBF2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-1D2
AC CVCL_G658
DR CLO; CLO_0006470
DR ATCC; CRL-2545
CC Monoclonal antibody target: UniProtKB; Q12772; Human SREBF2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-2A4
AC CVCL_G659
DR CLO; CLO_0006471
DR ATCC; CRL-2121
CC Monoclonal antibody target: UniProtKB; P36956; Human SREBF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-2F1
AC CVCL_G660
DR CLO; CLO_0006472
DR ATCC; CRL-2419
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-3B2
AC CVCL_G661
DR CLO; CLO_0006473
DR ATCC; CRL-2693
RX PubMed=11832248;
CC Monoclonal antibody target: UniProtKB; Q9VW37; Drosophila melanogaster SREBP.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-4A4
AC CVCL_G662
DR CLO; CLO_0006474
DR ATCC; CRL-1898
DR BCRC; 60033
RX PubMed=3320043;
CC Monoclonal antibody target: UniProtKB; P01130; Human LDLR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IgG-5D7
AC CVCL_G663
SY anti LRP 515
DR CLO; CLO_0006475
DR ATCC; CRL-1938
RX PubMed=2250029;
CC Monoclonal antibody target: UniProtKB; G1T4Z1; Rabbit LRP1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-6A6
AC CVCL_G664
DR CLO; CLO_0006476
DR ATCC; CRL-2197
DR ECACC; 97040309
CC Monoclonal antibody target: UniProtKB; P98166; Rat Vldlr (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-7D4
AC CVCL_G665
DR CLO; CLO_0006477
DR ATCC; CRL-2198
CC Monoclonal antibody target: UniProtKB; Q60429; Cricetulus griseus Srebf2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-9D5
AC CVCL_L598
DR CLO; CLO_0006478
DR ATCC; CRL-2347
RX PubMed=9242699;
CC Monoclonal antibody target: UniProtKB; P97260; Cricetulus griseus Scap.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgG-9D9
AC CVCL_E976
SY 9D9
DR CLO; CLO_0001539
DR ATCC; CRL-1703
RX PubMed=6088578;
CC Monoclonal antibody target: UniProtKB; P01131; Bovine LDLR (also reacts with rabbit).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IgG-B16
AC CVCL_G126
DR CLO; CLO_0006479
DR ATCC; CRL-1899
DR ECACC; 94080428
RX PubMed=2722817;
CC Monoclonal antibody target: Mesocricetus auratus OSBP (currently not in UniProtKB).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IgG-C7
AC CVCL_1971
SY C7
DR CLO; CLO_0002147
DR ATCC; CRL-1691
DR ECACC; 88090802
RX PubMed=3320043;
RX PubMed=6271765;
CC Monoclonal antibody target: UniProtKB; P01131; Bovine LDLR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IgH-2
AC CVCL_4346
SY IGH-2; Iguana Heart-2
DR CLO; CLO_0006481
DR CLDB; cl2608
DR ATCC; CCL-108
DR ECACC; 90030804
DR IZSLER; BS CL 185
RX PubMed=4314147;
RX PubMed=15621521;
RX PubMed=23891577;
CC Group: Reptilian cell line.
OX NCBI_TaxID=8517; ! Iguana iguana
SX Male
CA Spontaneously immortalized cell line
//
ID IGK
AC CVCL_1G92
SY Indian Grouper Kidney
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=17
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC017.
OX NCBI_TaxID=94232; ! Epinephelus coioides
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID iGM440
AC CVCL_EQ34
SY iPSC_GM03440; Normal iPSC from GM03440
DR GEO; GSM1184282
DR GEO; GSM1184283
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7388 ! GM03440
SX Male
CA Induced pluripotent stem cell
//
ID IGR-1
AC CVCL_1303
SY IGR 1; IGR1
DR CLO; CLO_0006669
DR CLDB; cl2624
DR BioSample; SAMN03472901
DR CCLE; IGR1_SKIN
DR ChEMBL-Cells; CHEMBL3308749
DR ChEMBL-Targets; CHEMBL1075479
DR CLS; 300219/p483_IGR-1
DR CLS; 300219-SF/p11286_IGR-1
DR Cosmic; 907169
DR Cosmic; 2230115
DR Cosmic-CLP; 907169
DR DSMZ; ACC-236
DR GDSC; 907169
DR GEO; GSM887157
DR GEO; GSM888229
DR GEO; GSM1669927
RX PubMed=405430;
RX PubMed=954556;
RX PubMed=6929009;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~75-100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Groin lymph node.
ST Source(s): CLS; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 13
ST D16S539: 11,13
ST D18S51: 16 (CLS)
ST D18S51: 14,16 (PubMed=25877200)
ST D21S11: 32.2
ST D3S1358: 14,17
ST D5S818: 10,11
ST D7S820: 10,11
ST D8S1179: 10 (CLS)
ST D8S1179: 10,14 (PubMed=25877200)
ST FGA: 23,24
ST Penta D: 10
ST Penta E: 7,11
ST TH01: 7,9.3 (CLS)
ST TH01: 9.3 (Cosmic-CLP; PubMed=25877200)
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IGR-2
AC CVCL_Y557
SY IGR 2
RX PubMed=405430;
RX PubMed=954556;
RX PubMed=6929009;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IGR-20
AC CVCL_Y559
SY IGR 20
RX PubMed=954556;
RX PubMed=6929009;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y560 ! IGR-22
SX Female
CA Finite cell line
//
ID IGR-22
AC CVCL_Y560
SY IGR 22
RX PubMed=405430;
RX PubMed=954556;
RX PubMed=6929009;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y559 ! IGR-20
SX Female
CA Cancer cell line
//
ID IGR-3
AC CVCL_Y558
SY IGR 3; IGR3
DR BTO; BTO:0005709
RX PubMed=954556;
RX PubMed=405430;
RX PubMed=6539703;
RX PubMed=6929009;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GR46 ! IGR-4
SX Male
CA Cancer cell line
//
ID IGR-31
AC CVCL_GR50
SY IGR 31
RX PubMed=405430;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IGR-36
AC CVCL_Y561
SY IGR 36
RX PubMed=954556;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y560 ! IGR-22
SX Female
CA Cancer cell line
//
ID IGR-37
AC CVCL_2075
SY IgR-37; IGR 37; IGR37; MM1
DR BTO; BTO:0005747
DR CLO; CLO_0006670
DR EFO; EFO_0006597
DR CLDB; cl2625
DR BioSample; SAMN03472906
DR CCLE; IGR37_SKIN
DR ChEMBL-Cells; CHEMBL3308435
DR ChEMBL-Targets; CHEMBL613985
DR Cosmic; 888064
DR Cosmic; 1995453
DR Cosmic-CLP; 1240153
DR DSMZ; ACC-237
DR GDSC; 1240153
DR GEO; GSM557941
DR GEO; GSM887158
DR GEO; GSM888230
DR GEO; GSM1669928
RX PubMed=405430;
RX PubMed=2344628;
RX PubMed=6539703;
RX PubMed=6929009;
RX PubMed=10709110;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~48-72 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Groin lymph node.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 14,15
ST D21S11: 31.2,32.2
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 14,15
ST FGA: 22
ST Penta D: 9
ST Penta E: 12,16
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,21
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2076 ! IGR-39
SX Male
CA Cancer cell line
//
ID IGR-39
AC CVCL_2076
SY IGR 39; IGR39; PM1
DR CLO; CLO_0006671
DR CLDB; cl2626
DR CCLE; IGR39_SKIN
DR Cosmic; 886828
DR Cosmic; 2163786
DR DSMZ; ACC-239
DR ESTDAB; ESTDAB-037
DR GEO; GSM557940
DR GEO; GSM557942
DR GEO; GSM887159
DR GEO; GSM888231
DR GEO; GSM1669929
RX PubMed=405430;
RX PubMed=2344628;
RX PubMed=6539703;
RX PubMed=6929009;
RX PubMed=22460905;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 34 hours (PubMed=25984343); ~30 hours (DSMZ).
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ESTDAB; ESTDAB-037; probable.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,21
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2075 ! IGR-37
SX Male
CA Cancer cell line
//
ID IGR-39D
AC CVCL_B491
SY IGR 39D; IGR39D
DR Cosmic; 1418459
RX PubMed=3402430;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2076 ! IGR-39
SX Male
CA Cancer cell line
//
ID IGR-4
AC CVCL_GR46
SY IGR 4; IGR4
RX PubMed=405430;
RX PubMed=6539703;
RX PubMed=6929009;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y558 ! IGR-3
SX Male
CA Cancer cell line
//
ID IGR-CaP1
AC CVCL_A018
RX Patent=US8674172;
RX PubMed=20974126;
RX PubMed=24525428;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4126.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IGR-CaP1-R100
AC CVCL_IR45
RX Patent=US8674172;
RX PubMed=24525428;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4127.
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A018 ! IGR-CaP1
SX Male
CA Cancer cell line
//
ID IGR-N-835
AC CVCL_8882
SY IGR-N835
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2777412;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IGR-N-91
AC CVCL_8883
SY IGR-N91; IGRN91
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=8101511;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IgR3
AC CVCL_GR43
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=9725211;
CC From: Hope R.; Genetics Department; University of Adelaide; Australia.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IGROV-1
AC CVCL_1304
SY Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P
DR BTO; BTO:0002575
DR CLO; CLO_0006672
DR EFO; EFO_0005385
DR CLDB; cl2627
DR BioSample; SAMN03470926
DR CCLE; IGROV1_OVARY
DR ChEMBL-Cells; CHEMBL3307502
DR ChEMBL-Targets; CHEMBL613984
DR Cosmic; 688100
DR Cosmic; 875857
DR Cosmic; 897430
DR Cosmic; 905968
DR Cosmic; 920360
DR Cosmic; 947357
DR Cosmic; 1044236
DR Cosmic; 1092607
DR Cosmic; 1102823
DR Cosmic; 1175880
DR Cosmic; 1305334
DR Cosmic; 1312353
DR Cosmic; 1707557
DR Cosmic; 1709252
DR Cosmic; 1998449
DR Cosmic; 2464669
DR Cosmic-CLP; 905968
DR GDSC; 905968
DR GEO; GSE23440
DR GEO; GSE25191
DR GEO; GSM50218
DR GEO; GSM50281
DR GEO; GSM313715
DR GEO; GSM750827
DR GEO; GSM799361
DR GEO; GSM799424
DR GEO; GSM844567
DR GEO; GSM844568
DR GEO; GSM844569
DR GEO; GSM844570
DR GEO; GSM846360
DR GEO; GSM851919
DR GEO; GSM887160
DR GEO; GSM888232
DR GEO; GSM1153432
DR GEO; GSM1181284
DR GEO; GSM1181285
DR GEO; GSM1374571
DR GEO; GSM1669930
DR Lonza; 175
DR SKY/M-FISH/CGH; 2739
RX PubMed=2041050;
RX PubMed=12960427;
RX PubMed=16319398;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22328975;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=23856246;
RX PubMed=23913215;
RX PubMed=23933261;
RX PubMed=24023729;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=26
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 30 hours (PubMed=25984343); 31 hours (DTP).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'IGROV-4' in PubMed=12960427.
CC Misspelling: 'IGR-OV1-RU' in Cosmic 1175880.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13,14,15 (Cosmic-CLP)
ST CSF1PO: 11,13 (PubMed=19372543)
ST CSF1PO: 11,16 (PubMed=25230021)
ST CSF1PO: 11,13,15 (PubMed=25877200)
ST D13S317: 8,10
ST D16S539: 11,12 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)
ST D16S539: 12 (PubMed=25230021)
ST D18S51: 14,16,17 (PubMed=25230021)
ST D18S51: 15,16 (PubMed=25877200)
ST D19S433: 13,14
ST D21S11: 26,29.2,30.2 (PubMed=25230021)
ST D21S11: 26,30.2 (PubMed=25877200)
ST D2S1338: 17,25
ST D3S1358: 13,15 (PubMed=19372543)
ST D3S1358: 13,14,15 (PubMed=25230021; PubMed=25877200)
ST D5S818: 12,13 (Cosmic-CLP; PubMed=19372543; PubMed=25230021)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 11 (Cosmic-CLP)
ST D7S820: 10 (PubMed=25877200)
ST D7S820: 9.1,10.1,11.1 (PubMed=25230021)
ST D8S1179: 14,16
ST FGA: 20,21,26 (PubMed=25230021)
ST FGA: 21,26 (PubMed=25877200)
ST Penta D: 8,10
ST Penta E: 13,17
ST TH01: 7,9.3
ST TPOX: 8,11,12 (Cosmic-CLP)
ST TPOX: 8,11 (PubMed=19372543; PubMed=25230021; PubMed=25877200)
ST vWA: 17,21 (Cosmic-CLP; PubMed=19372543)
ST vWA: 16,17,20,22 (PubMed=25230021)
ST vWA: 17,21,22 (PubMed=25877200)
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IGROV-1/25 ET
AC CVCL_8723
SY Igrov-1/25 ET
RX PubMed=10817511;
CC Selected for resistance to: ChEBI; CHEBI:84050; Trabectedin (Ecteinascidin-743; ET-743).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID IGROV-1/APL
AC CVCL_4Y61
RX PubMed=16258264;
CC Selected for resistance to: ChEBI; CHEBI:90205; Plitidepsin (Dehydrodidemnin B; Aplidin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID IGROV-1/CP
AC CVCL_IQ21
SY IGROV-1-CP; IGROV1CP
RX PubMed=16319398;
RX PubMed=23913215;
RX PubMed=27561551;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID IGROV-1/MX3
AC CVCL_EQ59
SY IGROV1/MX3; MX3
RX PubMed=10493507;
CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID IGROV-1/Pt0.5
AC CVCL_EQ61
SY IGROV1/Pt0.5
RX PubMed=9636834;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID IGROV-1/Pt1
AC CVCL_EQ62
SY IGROV1/Pt1
RX PubMed=9636834;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID IGROV-1/T8
AC CVCL_EQ60
SY IGROV1/T8; T8
DR GEO; GSM851943
RX PubMed=10493507;
CC Selected for resistance to: ChEBI; CHEBI:63632; Topotecan.
CC Omics: Transcriptome analysis.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID IGROV(T100r)
AC CVCL_4V48
RX PubMed=9635842;
CC Selected for resistance to: ChEBI; CHEBI:63632; Topotecan.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID IGRT-27
AC CVCL_GR51
SY IGRT 27
RX PubMed=405430;
RX PubMed=6929009;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID iGS1b8-2
AC CVCL_T945
AS CVCL_T889
SY A000001S8-2
DR RCB; HPS0064
DR SKIP; SKIP000017
DR SKIP; SKIP000268
DI NCIt; C84733; Glycogen storage disease type I
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T888 ! iGS1b8-6
SX Male
CA Induced pluripotent stem cell
//
ID iGS1b8-6
AC CVCL_T888
SY A000001S3-6
DR RCB; HPS0065
DR SKIP; SKIP000018
DI NCIt; C84733; Glycogen storage disease type I
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T945 ! iGS1b8-2
SX Male
CA Induced pluripotent stem cell
//
ID IGSK-1
AC CVCL_S832
RX PubMed=17506773;
CC Doubling time: ~34 hours (PubMed=17506773).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IGSK-2
AC CVCL_W378
RX PubMed=17547719;
CC Doubling time: ~83 hours (PubMed=17547719).
CC Derived from metastatic site: Ascites.
DI NCIt; C5248; Mucinous gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IGSK-3
AC CVCL_W377
RX PubMed=18667025;
CC Doubling time: ~43 hours (PubMed=18667025).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IgSV195
AC CVCL_AP98
RX PubMed=2502459;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6 x SJL) F2.
DI NCIt; C34035; Mouse pancreatic neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID IHCE
AC CVCL_6E29
SY Immortalized Human Corneal Endothelial cells
RX PubMed=23811495;
WW https://www.abmgood.com/Immortalized-Corneal-Endothelial-Cells-(IHCE)-T0577.html
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E30 ! IHCF
OI CVCL_6E31 ! IHCK
SX Male
CA Transformed cell line
//
ID iHCE-NY1
AC CVCL_BW58
SY immortalized Human Corneal Epithelial cell-NY1
RX PubMed=27130679;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IHCF
AC CVCL_6E30
SY Immortalized Human Corneal Fibroblasts
RX PubMed=23811495;
WW https://www.abmgood.com/Immortalized-Corneal-Fibroblasts-(IHCF)-T0578.html
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E29 ! IHCE
OI CVCL_6E31 ! IHCK
SX Male
CA Transformed cell line
//
ID IHCK
AC CVCL_6E31
SY Immortalized Human Corneal Keratinocytes
RX PubMed=23811495;
WW https://www.abmgood.com/Immortalized-Corneal-Keratinocytes-(IHCK)-T0579.html
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E29 ! IHCE
OI CVCL_6E30 ! IHCF
SX Male
CA Transformed cell line
//
ID ihFib3.2
AC CVCL_9S77
RX PubMed=26413783;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IHGGK
AC CVCL_F928
DR TKG; TKG 0623
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,9
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 7
ST TPOX: 9
ST vWA: 17,20
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IHGK
AC CVCL_6E42
SY Immortalized Human Gingival Keratinocytes
RX PubMed=8824527;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IHH
AC CVCL_8278
SY Immortalized Human Hepatocyte
DR Lonza; 8
RX PubMed=9298258;
RX PubMed=22594799;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IHH-4
AC CVCL_2960
SY IHH4
DR BioSample; SAMN03481111
DR Cosmic; 1995454
DR Cosmic; 2054088
DR Cosmic-CLP; 1240154
DR GDSC; 1240154
DR GEO; GSM827172
DR GEO; GSM1669931
DR JCRB; JCRB1079
DR JCRB; NIHS0270
DR JCRB; NIHS0270.1
DR JCRB; NIHS0271.1
RX PubMed=11686581;
RX PubMed=23833040;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0270; true.
CC Discontinued: JCRB; NIHS0270.1; true.
CC Discontinued: JCRB; NIHS0271.1; true.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10,13
ST D16S539: 9,11
ST D5S818: 9,13
ST D7S820: 9,10
ST TH01: 9
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IHKE-1
AC CVCL_0344
SY IHKE1; Immortalized Human Kidney Epithelial-1
DR MCCL; MCC:0000240
RX PubMed=2924322;
CC Transformant: ChEBI; CHEBI:49786; Nickel(2+).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IHL,AD031
AC CVCL_E708
SY IHL, AD031
DR dbMHC; 48904
DR ECACC; 94082216
DR IHW; IHW9117
DR IMGT/HLA; 11662
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl117.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IHL,AD036
AC CVCL_E709
SY IHL, AD036; TER89; TER188; TER235; TER279; TER421
DR dbMHC; 48905
DR ECACC; 94082223
DR IHW; IHW9124
DR IMGT/HLA; 10797
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl124.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ihNP
AC CVCL_T065
SY immortalized human Nucleus Pulposus
RX PubMed=23675702;
CC Doubling time: 53.16 +- 2.63 hours, at 25th passage (PubMed=23675702).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IHOK
AC CVCL_C191
SY Immortalized Human Oral Keratinocytes
RX PubMed=16011614;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID II b
AC CVCL_4347
SY B11
DR ECACC; 86072805
RX PubMed=3763403;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0439 ! MNNG/HOS Cl #5
HI CVCL_0594 ! NIH 3T3
CA Hybrid cell line
//
ID II-18
AC CVCL_6659
DR CLO; CLO_0050051
DR BioSample; SAMN03472059
DR Cosmic; 1239901
DR Cosmic; 2125265
DR RCB; RCB2093
DR TKG; TKG 0177
RX CelloPub=CLPUB00161;
RX PubMed=19472407;
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 7,12 (RCB)
ST CSF1PO: 12 (TKG)
ST D13S317: 12
ST D16S539: 10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 7
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IIB-BR-G
AC CVCL_B410
DR Cosmic; 1507366
RX PubMed=1661624;
RX PubMed=9620446;
RX PubMed=21308409;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IIB-BR-G-MT
AC CVCL_T742
DR Cosmic; 1507367
RX PubMed=9620446;
RX PubMed=21308409;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B410 ! IIB-BR-G
SX Female
CA Cancer cell line
//
ID IIC9
AC CVCL_4707
SY IIC9 (CH0)
DR BTO; BTO:0001894
DR ECACC; 00030814
RX PubMed=7088192;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_J502 ! CHEF/18
SX Male
CA Spontaneously immortalized cell line
//
ID IIIC-BCHM
AC CVCL_4409
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0160 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4410 ! IIIC/H2
OI CVCL_4414 ! IIICF/a2
OI CVCL_4415 ! IIICF/c
SX Female
CA Undefined cell line type
//
ID IIIC/H2
AC CVCL_4410
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0159 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4409 ! IIIC-BCHM
OI CVCL_4414 ! IIICF/a2
OI CVCL_4415 ! IIICF/c
SX Female
CA Undefined cell line type
//
ID IIICF-E6E7/C4
AC CVCL_4411
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0049 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4415 ! IIICF/c
SX Female
CA Transformed cell line
//
ID IIICF-T/A6
AC CVCL_4412
SY LTAG-transformed IIICF clone A6
RX PubMed=8108114;
RX PubMed=9175740;
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0055 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4415 ! IIICF/c
SX Female
CA Transformed cell line
//
ID IIICF-T/B1
AC CVCL_6F12
SY LTAG-transformed IIICF clone B1
RX PubMed=8108114;
RX PubMed=9175740;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4415 ! IIICF/c
SX Female
CA Transformed cell line
//
ID IIICF-T/B3
AC CVCL_4413
SY LTAG-transformed IIICF clone B3
RX PubMed=8108114;
RX PubMed=19468068;
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0056 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4415 ! IIICF/c
SX Female
CA Transformed cell line
//
ID IIICF-T/C3
AC CVCL_6F13
SY LTAG-transformed IIICF clone C3
RX PubMed=8108114;
RX PubMed=9175740;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4415 ! IIICF/c
SX Female
CA Transformed cell line
//
ID IIICF/a2
AC CVCL_4414
SY III-CF culture A2
RX PubMed=22829774;
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0048 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4409 ! IIIC-BCHM
OI CVCL_4410 ! IIIC/H2
OI CVCL_4415 ! IIICF/c
SX Female
CA Spontaneously immortalized cell line
//
ID IIICF/c
AC CVCL_4415
SY III-CF/c; III-CF culture C
RX PubMed=7651392;
RX PubMed=9175740;
RX PubMed=19468068;
RX PubMed=22829774;
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0039 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4409 ! IIIC-BCHM
OI CVCL_4410 ! IIIC/H2
OI CVCL_4414 ! IIICF/a2
SX Female
CA Spontaneously immortalized cell line
//
ID IIICF/c/rasT21
AC CVCL_4416
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0040 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4415 ! IIICF/c
SX Female
CA Transformed cell line
//
ID IISH1i-BM1
AC CVCL_U166
SY BM1 iPSC
DR ISCR; 2121
RX PubMed=21296996;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/iish1i-bm1.cmsx
WW http://shared.eagle-i.net/i/00000144-8e6b-2415-5797-c9ee80000000
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IISH2i-BM9
AC CVCL_U167
SY BM9 iPSC
DR ISCR; 2083
RX PubMed=21296996;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/iish2i-bm9.cmsx
WW http://shared.eagle-i.net/i/00000144-8e6e-6b2e-5797-c9ee80000000
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IISH3i-CB6
AC CVCL_U168
SY CB iPSC6
DR ISCR; 2122
RX PubMed=21296996;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/iish3i-cb6.cmsx
WW http://shared.eagle-i.net/i/00000144-8e35-3a75-5797-c9ee80000000
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IISH6i-CML17
AC CVCL_U169
SY CMLiPS17
DR ISCR; 2123
RX PubMed=21296996;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/iish6i-cml17.cmsx
WW http://shared.eagle-i.net/i/00000144-8e63-fffa-5797-c9ee80000000
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IK-15
AC CVCL_N278
SY NBnu834-2
DR ATCC; CRL-7930
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7930; true.
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID IK-6
AC CVCL_N296
SY NBNu804-1Tu
DR ATCC; CRL-7929
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7929; true.
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID IK-90
AC CVCL_9996
DR Cosmic; 735334
RX PubMed=3815380;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID IKK-i-DEF
AC CVCL_4W56
DR JCRB; JCRB1534
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID IL-A105
AC CVCL_L564
DR ECACC; 91072535
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A11
AC CVCL_G127
DR CLO; CLO_0006694
DR ATCC; CRL-1879
DR ECACC; 91072511
RX PubMed=2423591;
CC Monoclonal antibody target: UniProtKB; I0J0K0; Bovine CD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID IL-A12
AC CVCL_L579
RX PubMed=2423591;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID IL-A16
AC CVCL_L565
DR ECACC; 91072514
CC Monoclonal antibody target: Bovine ITGAX/CD11c (currently not in UniProtKB).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A19
AC CVCL_L566
DR ECACC; 91072515
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A2
AC CVCL_L567
DR ECACC; 91072510
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A21
AC CVCL_L568
DR ECACC; 91072516
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A24
AC CVCL_L569
DR ECACC; 91072517
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A29
AC CVCL_G128
DR CLO; CLO_0006695
DR ATCC; CRL-1874
DR ECACC; 91072519
CC Monoclonal antibody target: UniProtKB; P30205; Bovine WC1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A30
AC CVCL_G129
DR CLO; CLO_0006696
DR ATCC; CRL-1894
DR ECACC; 91072520
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A42
AC CVCL_G130
DR CLO; CLO_0006697
DR ATCC; CRL-1870
DR ECACC; 91072521
CC Monoclonal antibody target: UniProtKB; Q148M9; Bovine CD2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A43
AC CVCL_L570
DR ECACC; 91072522
CC Monoclonal antibody target: UniProtKB; Q148M9; Bovine CD2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A46
AC CVCL_L571
DR ECACC; 91072523
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A50
AC CVCL_L572
DR ECACC; 91072524
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A51
AC CVCL_G131
DR CLO; CLO_0006698
DR ATCC; CRL-1871
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A54
AC CVCL_CY51
RX PubMed=2021068;
CC Monoclonal antibody target: Bovine WC5 antigen (BoWC5).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A55
AC CVCL_CY52
RX PubMed=2021068;
CC Monoclonal antibody target: Bovine WC5 antigen (BoWC5).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A57
AC CVCL_L573
DR ECACC; 91072526
CC Monoclonal antibody target: UniProtKB; F1MU15; Bovine CD6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A58
AC CVCL_L574
DR ECACC; 91072527
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A59
AC CVCL_L575
DR ECACC; 91072528
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A60
AC CVCL_L576
DR ECACC; 91072529
CC Discontinued: ECACC; 91072529; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A71
AC CVCL_L577
DR ECACC; 91072532
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IL-A88
AC CVCL_L578
DR ECACC; 91072534
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID ILB1-H21
AC CVCL_J752
SY ILB1-H21B2B
DR CLO; CLO_0006699
DR ATCC; HB-10220
RX Patent=US4935343;
CC Monoclonal antibody target: UniProtKB; P01584; Human IL1B.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID ILB1-H34
AC CVCL_J753
SY ILB1-H34A3
DR CLO; CLO_0006700
DR ATCC; HB-10221
RX Patent=US4935343;
CC Monoclonal antibody target: UniProtKB; P01584; Human IL1B.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID ILB1-H6
AC CVCL_J754
SY ILB1-H6A1B
DR CLO; CLO_0006701
DR ATCC; HB-10219
RX Patent=US4935343;
CC Monoclonal antibody target: UniProtKB; P01584; Human IL1B.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID ILB1-H67
AC CVCL_J755
DR CLO; CLO_0006702
DR ATCC; HB-10222
RX Patent=US4935343;
CC Monoclonal antibody target: UniProtKB; P01584; Human IL1B.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID ILKM10
AC CVCL_M544
SY ILKM-10
DR CGH-DB; 10-1
DR CGH-DB; 9152-4
RX PubMed=15215163;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ILKM12
AC CVCL_M499
SY ILKM-12
DR CGH-DB; 11-1
DR CGH-DB; 9153-4
RX PubMed=15215163;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ILKM13
AC CVCL_M500
SY ILKM-13
DR CGH-DB; 12-1
DR CGH-DB; 9154-4
RX PubMed=15215163;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ILKM2
AC CVCL_A621
SY ILKM-2
DR CGH-DB; 9149-4
RX PubMed=2783335;
RX PubMed=10936422;
RX PubMed=11429052;
RX PubMed=12886255;
RX PubMed=15215163;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ILKM3
AC CVCL_A622
SY ILKM-3
DR CGH-DB; 9150-4
DR Cosmic; 688961
RX PubMed=2783335;
RX PubMed=10936422;
RX PubMed=11429052;
RX PubMed=12886255;
RX PubMed=15215163;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ILKM8
AC CVCL_M497
SY ILKM-8
DR CGH-DB; 9151-4
RX PubMed=10557056;
RX PubMed=11429052;
RX PubMed=15215163;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ILT-As
AC CVCL_F909
RX PubMed=6189906;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G008 ! TCL-As
SX Male
CA Transformed cell line
//
ID ILT-Mat
AC CVCL_A782
DR CLO; CLO_0050973
DR BioSample; SAMN03472321
DR RCB; RCB0475
DR TKG; TKG 0286
RX PubMed=6088403;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G015 ! TL-Mat
SX Male
CA Transformed cell line
//
ID ILT-Mor
AC CVCL_F910
RX PubMed=6088403;
RX PubMed=6189906;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G011 ! TCL-Mor
OI CVCL_0074 ! TL-Mor
SX Male
CA Transformed cell line
//
ID ILT-My
AC CVCL_F911
RX PubMed=6189906;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ILT-Om
AC CVCL_F912
RX PubMed=6189906;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G007 ! PBL-Om
SX Male
CA Transformed cell line
//
ID ILT-Su
AC CVCL_F913
RX PubMed=6189906;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G013 ! TL-Su
SX Male
CA Transformed cell line
//
ID ILT-Ter
AC CVCL_F914
RX PubMed=6189906;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_G012 ! TCL-Ter
SX Male
CA Transformed cell line
//
ID ILT-Yan
AC CVCL_F915
RX PubMed=6189906;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IM
AC CVCL_W444
RX PubMed=9183668;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IM-2
AC CVCL_S548
RX PubMed=2466037;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID IM-9
AC CVCL_1305
SY IM 9; IM9; GM04680
DR BTO; BTO:0002897
DR CLO; CLO_0006703
DR CLO; CLO_0006705
DR CLO; CLO_0019036
DR CLDB; cl2635
DR CLDB; cl2636
DR CLDB; cl2637
DR CLDB; cl4962
DR CLDB; cl5210
DR ATCC; CCL-159
DR BCRC; 60115
DR BioSample; SAMN03471460
DR BioSample; SAMN03472807
DR CCRID; 3111C0002000000064
DR ChEMBL-Cells; CHEMBL3307412
DR ChEMBL-Targets; CHEMBL614584
DR Coriell; GM04680
DR Cosmic; 753563
DR Cosmic; 888021
DR Cosmic; 919137
DR Cosmic-CLP; 753563
DR DSMZ; ACC-117
DR ECACC; 86051302
DR GDSC; 753563
DR GEO; GSM1374572
DR GEO; GSM1669932
DR ICLC; HTL99009
DR IZSLER; BS TCL 98
DR IFO; IFO50025
DR JCRB; JCRB0024
DR KCLB; 10159
DR Lonza; 9
RX PubMed=7579375;
RX PubMed=9290701;
RX PubMed=10516762;
RX PubMed=10936422;
RX PubMed=27397505;
CC Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
CC Doubling time: ~45 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; JCRB; KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 9,13
ST D3S1358: 14,18
ST D5S818: 13
ST D7S820: 11,12
ST FGA: 20,23
ST TH01: 6,9.3 (ATCC; Cosmic-CLP; DSMZ; KCLB)
ST TH01: 6,10 (JCRB)
ST TPOX: 11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IM-Ep-1
AC CVCL_S574
SY Ep-1
RX PubMed=1473147;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S548 ! IM-2
SX Female
CA Spontaneously immortalized cell line
//
ID IM7.8.1
AC CVCL_9184
DR CLO; CLO_0006704
DR ATCC; TIB-235
CC Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4696 ! S194/5.XXO.BU.1
CA Hybridoma
//
ID IM95
AC CVCL_2961
SY Im95; IM-95
DR BTO; BTO:0005908
DR EFO; EFO_0006446
DR BioSample; SAMN03470904
DR CCLE; IM95_STOMACH
DR Cosmic; 1187278
DR Cosmic; 1482079
DR Cosmic; 1995455
DR Cosmic; 2443798
DR Cosmic-CLP; 1240155
DR GDSC; 1240155
DR GEO; GSM562403
DR GEO; GSM827403
DR GEO; GSM844571
DR GEO; GSM887161
DR GEO; GSM888233
DR GEO; GSM1237675
DR GEO; GSM1237700
DR GEO; GSM1374573
DR GEO; GSM1669933
DR JCRB; JCRB1075.0
DR JCRB; NIHS0333
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0333; true.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,12
ST D16S539: 9,10
ST D18S51: 14,23,24
ST D19S433: 12,13
ST D21S11: 31,32.2
ST D2S1338: 18
ST D3S1358: 14
ST D5S818: 9,11
ST D7S820: 9.3
ST D8S1179: 12,13
ST FGA: 19,21
ST Penta D: 10,12
ST Penta E: 12
ST TH01: 6,10
ST TPOX: 8,10
ST vWA: 17,19 (Cosmic-CLP)
ST vWA: 17,18,19 (JCRB; PubMed=25877200)
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IM95/CMV-Luc
AC CVCL_4Y04
DR JCRB; NIHS0712
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2961 ! IM95
SX Male
CA Cancer cell line
//
ID IM95m
AC CVCL_2962
SY IM95M; IM-95m
DR EFO; EFO_0006598
DR BioSample; SAMN03473261
DR Cosmic; 2484953
DR GEO; GSM844572
DR GEO; GSM1374574
DR JCRB; JCRB1075.1
DR JCRB; NIHS0334
RX PubMed=14609362;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0334; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,12
ST D16S539: 9,10
ST D18S51: 13,23
ST D21S11: 31,32.2
ST D3S1358: 14
ST D5S818: 9,11
ST D7S820: 9.3
ST D8S1179: 12,13
ST FGA: 19,21
ST Penta D: 10,11
ST Penta E: 12
ST TH01: 6,10
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2961 ! IM95
SX Male
CA Cancer cell line
//
ID IMa
AC CVCL_M688
SY IMA
DR Cosmic; 1820649
RX PubMed=6683709;
DI NCIt; C4515; Ovarian choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IMA 2.1
AC CVCL_X370
SY IMA2.1
RX PubMed=22847254;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID IMC-1
AC CVCL_EQ57
DR GEO; GSM471998
RX PubMed=14687616;
RX PubMed=14687623;
RX PubMed=21052088;
CC Characteristics: IL2 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IMC-2
AC CVCL_8245
SY IMC2
DR BioSample; SAMN03151720
DR RCB; RCB0726
RX PubMed=1610070;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388). Originally thought to originate from a maxillary carcinoma from a male patient (from which IMC-3 and IMC-4 were also supposed to be derived).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: RCB; RCB0726; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID IMC-3
AC CVCL_8246
DR BioSample; SAMN03151721
DR RCB; RCB0727
RX PubMed=1610070;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a maxillary carcinoma from a male patient (from which IMC-2 and IMC-4 were also supposed to be derived).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: RCB; RCB0727; true.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 16
ST D21S11: 27,28
ST D8S1179: 12
ST FGA: 18,21
ST TH01: 7
ST vWA: 16,19
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID IMC-4
AC CVCL_8247
DR BioSample; SAMN03151722
DR RCB; RCB0728
RX PubMed=1610070;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a maxillary carcinoma from a male patient (from which IMC-2 and IMC-3 were also supposed to be derived).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: RCB; RCB0728; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID IMC-HZ-1
AC CVCL_AV27
RX PubMed=5463775;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Female
CA Spontaneously immortalized cell line
//
ID IMCC3
AC CVCL_E238
DR GEO; GSM851920
WW http://www.addexbio.com/productdetail?pid=446
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IMCC5
AC CVCL_E239
DR GEO; GSM851921
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IMDF
AC CVCL_U509
RX PubMed=12089160;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-484.html
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID IMEC
AC CVCL_U969
SY Immortalized Mammary Epithelial Cells
DR BTO; BTO:0004896
RX PubMed=11782364;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID iMELA1
AC CVCL_Y912
SY A000024#1; A000024# 1
DR RCB; HPS0069
DR SKIP; SKIP000022
DI NCIt; C84885; MELAS syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T946 ! iMELA2
OI CVCL_Y913 ! iMELA3
SX Male
CA Induced pluripotent stem cell
//
ID iMELA2
AC CVCL_T946
SY A000024#2; A000024# 2
DR RCB; HPS0070
DR SKIP; SKIP000023
DR SKIP; SKIP000269
DI NCIt; C84885; MELAS syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y912 ! iMELA1
OI CVCL_Y913 ! iMELA3
SX Male
CA Induced pluripotent stem cell
//
ID iMELA3
AC CVCL_Y913
SY A000024#3; A000024# 3
DR RCB; HPS0071
DR SKIP; SKIP000024
DI NCIt; C84885; MELAS syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y912 ! iMELA1
OI CVCL_T946 ! iMELA2
SX Male
CA Induced pluripotent stem cell
//
ID iMESO-NF3
AC CVCL_4Z44
RX PubMed=25877069;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID iMESO-NF5
AC CVCL_4Z45
RX PubMed=25877069;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID iMESO-NF6
AC CVCL_4Z46
RX PubMed=25877069;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID iMESO-WT1
AC CVCL_4Z47
RX PubMed=25877069;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID iMESO-WT2
AC CVCL_4Z48
RX PubMed=25877069;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID iMESO-WT3
AC CVCL_4Z49
RX PubMed=25877069;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID IMG
AC CVCL_HC49
SY Immortalized MicroGlial cell line
RX PubMed=26819091;
WW https://www.kerafast.com/product/2636/microglial-cell-line-img
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID IMG-1021 XP4MO
AC CVCL_IM47
DR CLO; CLO_0006714
DR CLDB; cl2646
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-1024 XP5MO
AC CVCL_IM48
DR CLO; CLO_0006716
DR CLDB; cl2648
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-1028 XP6MO
AC CVCL_IM49
DR CLO; CLO_0006719
DR CLDB; cl2651
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-1080 XP7MO
AC CVCL_IM50
DR CLO; CLO_0006736
DR CLDB; cl2668
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-1217 XP8MO
AC CVCL_IM51
DR CLO; CLO_0006772
DR CLDB; cl2704
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-1247 XP9MO
AC CVCL_IM52
DR CLO; CLO_0006779
DR CLDB; cl2711
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-484 XP2MO
AC CVCL_IM53
DR CLO; CLO_0006814
DR CLDB; cl2746
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-638 XP3LE
AC CVCL_IM54
DR CLO; CLO_0006821
DR CLDB; cl2753
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-667 XP2LE
AC CVCL_IM55
DR CLO; CLO_0006828
DR CLDB; cl2760
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-730 XP3MO
AC CVCL_IM56
DR CLO; CLO_0006851
DR CLDB; cl2783
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-990 XP3Br2
AC CVCL_IM57
DR CLO; CLO_0006938
DR CLDB; cl2870
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IMG-991 XP3ORO
AC CVCL_IM58
DR CLO; CLO_0006939
DR CLDB; cl2871
CC From: MWCMG; Russian Academy of Medical Sciences; Moscow; Russia.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID imHCE_GDLD
AC CVCL_T054
RX PubMed=23868985;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IMIM-PC1
AC CVCL_4061
SY IMIM-PC-1; IMIMPC1
DR Cosmic; 948736
RX PubMed=7723277;
RX PubMed=9665481;
RX PubMed=11169957;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=IMIM-PC-1
CC Derived from metastatic site: Liver.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IMIM-PC2
AC CVCL_0345
SY IMIM-PC-2; IMIMPC2
DR MCCL; MCC:0000241
DR Cosmic; 710859
DR Cosmic; 948728
RX PubMed=7723277;
RX PubMed=9665481;
RX PubMed=11169957;
RX PubMed=11787853;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=IMIM-PC-2
CC Misspelling: Occasionally 'IMM-PC2'.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ImKC
AC CVCL_HF55
SY Immortalized Kupffer Cells
RX PubMed=25138015;
CC Doubling time: ~24 hours (PubMed=25138015).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID IMM002.69.47.4
AC CVCL_L543
DR CLO; CLO_0006946
DR ATCC; CRL-13007
DR ATCC; PTA-450
RX Patent=US6376654;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IMM010.109.12
AC CVCL_L795
SY MoAb 109.12
DR ATCC; PTA-2357
RX Patent=US7183389;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IMM010.26.1
AC CVCL_L796
SY MoAb 26.1
DR ATCC; PTA-2359
RX Patent=US7183389;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IMM010.37.14
AC CVCL_L797
SY MoAb 37.14
DR ATCC; PTA-2358
RX Patent=US7183389;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IMM010.51.2
AC CVCL_L798
SY MoAb 51.2
DR ATCC; PTA-2360
RX Patent=US7183389;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ImM10
AC CVCL_J384
SY Immortmouse Muller P10
RX PubMed=20505190;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IMO-1G1
AC CVCL_D792
SY IMO1G1
RX PubMed=12382283;
RX PubMed=15517566;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IMO-2B1
AC CVCL_D793
SY IMO2B1
RX PubMed=12382283;
RX PubMed=15517566;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IMO-2D2
AC CVCL_D794
SY IMO2D2
RX PubMed=12382283;
RX PubMed=15517566;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IMO-2D3
AC CVCL_D795
SY IMO2D3
RX PubMed=12382283;
RX PubMed=15517566;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IMO-3A1
AC CVCL_D796
SY IMO3A1
RX PubMed=12382283;
RX PubMed=15517566;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
- 公告/新闻
免费订购电话: 400-800-2947